[
{
"ID": "1",
"agreement_id": "11",
"nct_id": "NCT00006170",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2",
"agreement_id": "12",
"nct_id": "NCT00006178",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "3",
"agreement_id": "13",
"nct_id": "NCT00006184",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "4",
"agreement_id": "14",
"nct_id": "NCT00006237",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "5",
"agreement_id": "15",
"nct_id": "NCT00006305",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "6",
"agreement_id": "16",
"nct_id": "NCT00006389",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "7",
"agreement_id": "17",
"nct_id": "NCT00006392",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "8",
"agreement_id": "18",
"nct_id": "NCT00006409",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "9",
"agreement_id": "19",
"nct_id": "NCT00006478",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "10",
"agreement_id": "20",
"nct_id": "NCT00006721",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "11",
"agreement_id": "21",
"nct_id": "NCT00006903",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "12",
"agreement_id": "22",
"nct_id": "NCT00006916",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "13",
"agreement_id": "23",
"nct_id": "NCT00007644",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "14",
"agreement_id": "24",
"nct_id": "NCT00008138",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "15",
"agreement_id": "25",
"nct_id": "NCT00010257",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "16",
"agreement_id": "26",
"nct_id": "NCT00010439",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Agreement with Merck: to submit a copy of any proposed abstract, manuscript and\/or press release to Merck for review and comment at least 30 days prior to submission for publication or presentation.'"
},
{
"ID": "17",
"agreement_id": "27",
"nct_id": "NCT00010803",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "18",
"agreement_id": "28",
"nct_id": "NCT00012012",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "19",
"agreement_id": "29",
"nct_id": "NCT00013611",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "20",
"agreement_id": "30",
"nct_id": "NCT00014560",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "21",
"agreement_id": "31",
"nct_id": "NCT00014911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "22",
"agreement_id": "32",
"nct_id": "NCT00015457",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "23",
"agreement_id": "33",
"nct_id": "NCT00015847",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "24",
"agreement_id": "34",
"nct_id": "NCT00016354",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "25",
"agreement_id": "35",
"nct_id": "NCT00017563",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "26",
"agreement_id": "36",
"nct_id": "NCT00018031",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "27",
"agreement_id": "43",
"nct_id": "NCT00000575",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "28",
"agreement_id": "44",
"nct_id": "NCT00000620",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "29",
"agreement_id": "45",
"nct_id": "NCT00001151",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "30",
"agreement_id": "46",
"nct_id": "NCT00001213",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "31",
"agreement_id": "47",
"nct_id": "NCT00001566",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "32",
"agreement_id": "48",
"nct_id": "NCT00001586",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "33",
"agreement_id": "49",
"nct_id": "NCT00001596",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "34",
"agreement_id": "50",
"nct_id": "NCT00001656",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "35",
"agreement_id": "51",
"nct_id": "NCT00001703",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "36",
"agreement_id": "52",
"nct_id": "NCT00001723",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "37",
"agreement_id": "53",
"nct_id": "NCT00001832",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "38",
"agreement_id": "54",
"nct_id": "NCT00001941",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "39",
"agreement_id": "55",
"nct_id": "NCT00001959",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "40",
"agreement_id": "56",
"nct_id": "NCT00001962",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "41",
"agreement_id": "57",
"nct_id": "NCT00001984",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "42",
"agreement_id": "58",
"nct_id": "NCT00002540",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "43",
"agreement_id": "59",
"nct_id": "NCT00002850",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "44",
"agreement_id": "60",
"nct_id": "NCT00002975",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "45",
"agreement_id": "61",
"nct_id": "NCT00003138",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "46",
"agreement_id": "62",
"nct_id": "NCT00003222",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "47",
"agreement_id": "63",
"nct_id": "NCT00003224",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "48",
"agreement_id": "64",
"nct_id": "NCT00003298",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "49",
"agreement_id": "65",
"nct_id": "NCT00003377",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "50",
"agreement_id": "66",
"nct_id": "NCT00003389",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "51",
"agreement_id": "67",
"nct_id": "NCT00003590",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "52",
"agreement_id": "68",
"nct_id": "NCT00003659",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "53",
"agreement_id": "69",
"nct_id": "NCT00003782",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "54",
"agreement_id": "1",
"nct_id": "NCT00004980",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "55",
"agreement_id": "2",
"nct_id": "NCT00005669",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "56",
"agreement_id": "3",
"nct_id": "NCT00005906",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "57",
"agreement_id": "4",
"nct_id": "NCT00005908",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "58",
"agreement_id": "5",
"nct_id": "NCT00005937",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "59",
"agreement_id": "6",
"nct_id": "NCT00005947",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.'"
},
{
"ID": "60",
"agreement_id": "7",
"nct_id": "NCT00006011",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "61",
"agreement_id": "8",
"nct_id": "NCT00006151",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "62",
"agreement_id": "9",
"nct_id": "NCT00006156",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "63",
"agreement_id": "10",
"nct_id": "NCT00006164",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "64",
"agreement_id": "97",
"nct_id": "NCT00031486",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "65",
"agreement_id": "98",
"nct_id": "NCT00031694",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "66",
"agreement_id": "99",
"nct_id": "NCT00032487",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "67",
"agreement_id": "100",
"nct_id": "NCT00032591",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "68",
"agreement_id": "101",
"nct_id": "NCT00032630",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "69",
"agreement_id": "102",
"nct_id": "NCT00033371",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "70",
"agreement_id": "103",
"nct_id": "NCT00033540",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "71",
"agreement_id": "104",
"nct_id": "NCT00033657",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "72",
"agreement_id": "105",
"nct_id": "NCT00033917",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "73",
"agreement_id": "106",
"nct_id": "NCT00035555",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "74",
"agreement_id": "107",
"nct_id": "NCT00035815",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "75",
"agreement_id": "37",
"nct_id": "NCT00000125",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "76",
"agreement_id": "38",
"nct_id": "NCT00000134",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "77",
"agreement_id": "39",
"nct_id": "NCT00000371",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "78",
"agreement_id": "40",
"nct_id": "NCT00000378",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "79",
"agreement_id": "41",
"nct_id": "NCT00000392",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "80",
"agreement_id": "42",
"nct_id": "NCT00000479",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "81",
"agreement_id": "83",
"nct_id": "NCT00027027",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "82",
"agreement_id": "84",
"nct_id": "NCT00027378",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "83",
"agreement_id": "85",
"nct_id": "NCT00027560",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "84",
"agreement_id": "86",
"nct_id": "NCT00028002",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "85",
"agreement_id": "87",
"nct_id": "NCT00028093",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "86",
"agreement_id": "88",
"nct_id": "NCT00028262",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "87",
"agreement_id": "89",
"nct_id": "NCT00028769",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "88",
"agreement_id": "90",
"nct_id": "NCT00029107",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "89",
"agreement_id": "91",
"nct_id": "NCT00029146",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "90",
"agreement_id": "92",
"nct_id": "NCT00029172",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "91",
"agreement_id": "93",
"nct_id": "NCT00030901",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "92",
"agreement_id": "94",
"nct_id": "NCT00030992",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "93",
"agreement_id": "95",
"nct_id": "NCT00031447",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "94",
"agreement_id": "108",
"nct_id": "NCT00035932",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "95",
"agreement_id": "109",
"nct_id": "NCT00036270",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "96",
"agreement_id": "110",
"nct_id": "NCT00036569",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "97",
"agreement_id": "111",
"nct_id": "NCT00037830",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "98",
"agreement_id": "112",
"nct_id": "NCT00038103",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "99",
"agreement_id": "113",
"nct_id": "NCT00038467",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "100",
"agreement_id": "114",
"nct_id": "NCT00038610",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "101",
"agreement_id": "115",
"nct_id": "NCT00038857",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "102",
"agreement_id": "116",
"nct_id": "NCT00038948",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "103",
"agreement_id": "117",
"nct_id": "NCT00039130",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval'"
},
{
"ID": "104",
"agreement_id": "118",
"nct_id": "NCT00039377",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "105",
"agreement_id": "119",
"nct_id": "NCT00039741",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "106",
"agreement_id": "120",
"nct_id": "NCT00039871",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "107",
"agreement_id": "121",
"nct_id": "NCT00040365",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "108",
"agreement_id": "122",
"nct_id": "NCT00040664",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "109",
"agreement_id": "123",
"nct_id": "NCT00040742",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "110",
"agreement_id": "124",
"nct_id": "NCT00040937",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "111",
"agreement_id": "125",
"nct_id": "NCT00041067",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "112",
"agreement_id": "126",
"nct_id": "NCT00041080",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "113",
"agreement_id": "127",
"nct_id": "NCT00041132",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "114",
"agreement_id": "128",
"nct_id": "NCT00041392",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "115",
"agreement_id": "129",
"nct_id": "NCT00041717",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.'"
},
{
"ID": "116",
"agreement_id": "130",
"nct_id": "NCT00041756",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "117",
"agreement_id": "131",
"nct_id": "NCT00041938",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "118",
"agreement_id": "132",
"nct_id": "NCT00042432",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "119",
"agreement_id": "145",
"nct_id": "NCT00048724",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator agrees to provide review copies to the sponsor 30 days prior to submission for publication or presentation. The sponsor shall have editorial rights and the right to review and comment on the data analysis and presentation. If the parties disagree, investigator agrees to meet with the sponsor's representatives for the purpose of making good faith efforts to discuss and resolve any such issues.'"
},
{
"ID": "120",
"agreement_id": "146",
"nct_id": "NCT00048737",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "121",
"agreement_id": "147",
"nct_id": "NCT00048893",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "122",
"agreement_id": "148",
"nct_id": "NCT00048932",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "123",
"agreement_id": "149",
"nct_id": "NCT00048997",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "124",
"agreement_id": "150",
"nct_id": "NCT00049036",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "125",
"agreement_id": "151",
"nct_id": "NCT00049127",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "126",
"agreement_id": "152",
"nct_id": "NCT00049257",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The obligations of confidentiality shall apply for a period of 5 yrs beyond termination of Agreement between Sponsor and Investigator,but do not apply to the extent information:is or later becomes known to public;is obtained from a third party without restriction who had a legal right to disclose;is possessed by Investigators,as demonstrated by recipient\u2019s written records predating receipt from Sponsor;is required to be disclosed pursuant to a subpoena, law, regulation or other legal proceeding.'"
},
{
"ID": "127",
"agreement_id": "153",
"nct_id": "NCT00049517",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "128",
"agreement_id": "154",
"nct_id": "NCT00049530",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "129",
"agreement_id": "155",
"nct_id": "NCT00049543",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "130",
"agreement_id": "156",
"nct_id": "NCT00049842",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No public presentation\/publication of any interim results will be made by any principal investigator (PI) or any other member of the study staff without the Sponsor's prior written consent. The PI further agrees to provide to the sponsor 30 days prior to submission, review copies that report any results of the study. The sponsor shall have the right to review, comment, and edit. If the parties disagree, the PI agrees to meet with the sponsor to discuss and resolve any such issues\/disagreement.'"
},
{
"ID": "131",
"agreement_id": "157",
"nct_id": "NCT00050011",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.'"
},
{
"ID": "132",
"agreement_id": "158",
"nct_id": "NCT00050089",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "133",
"agreement_id": "159",
"nct_id": "NCT00050167",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "134",
"agreement_id": "160",
"nct_id": "NCT00050778",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after sponsor publishes or 18 months after study completion. PI gives sponsor a draft 60 days before publication. Sponsor can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "135",
"agreement_id": "161",
"nct_id": "NCT00050960",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "136",
"agreement_id": "162",
"nct_id": "NCT00050986",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "137",
"agreement_id": "163",
"nct_id": "NCT00051025",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "138",
"agreement_id": "164",
"nct_id": "NCT00051168",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "139",
"agreement_id": "165",
"nct_id": "NCT00051558",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "140",
"agreement_id": "166",
"nct_id": "NCT00051636",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "141",
"agreement_id": "167",
"nct_id": "NCT00052962",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "142",
"agreement_id": "133",
"nct_id": "NCT00042939",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "143",
"agreement_id": "134",
"nct_id": "NCT00004412",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "144",
"agreement_id": "135",
"nct_id": "NCT00004500",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "145",
"agreement_id": "136",
"nct_id": "NCT00004547",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "146",
"agreement_id": "137",
"nct_id": "NCT00004562",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The NIH Public Access Policy ensures that the public has access to the published results of NIH funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central upon acceptance for publication. To help advance science and improve human health, the Policy requires that these papers are accessible to the public on PubMed Central no later than 12 months after publication.'"
},
{
"ID": "147",
"agreement_id": "138",
"nct_id": "NCT00004563",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "148",
"agreement_id": "139",
"nct_id": "NCT00004635",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "149",
"agreement_id": "140",
"nct_id": "NCT00004732",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "150",
"agreement_id": "141",
"nct_id": "NCT00004859",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "151",
"agreement_id": "142",
"nct_id": "NCT00004888",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "152",
"agreement_id": "143",
"nct_id": "NCT00004978",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "153",
"agreement_id": "144",
"nct_id": "NCT00048581",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "154",
"agreement_id": "96",
"nct_id": "NCT00031460",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "155",
"agreement_id": "227",
"nct_id": "NCT00066963",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "156",
"agreement_id": "228",
"nct_id": "NCT00067236",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Data, calculations, interpretations, opinions, and recommendations will be the property of P&GP. Manuscripts for publication will be drafted by the Expert Panel which will select appropriate journals in which to publish. P&GP, through its Expert Panel representation, will provide technical\/editorial\/review assistance. Other manuscript(s) will supported as appropriate. These materials must be submitted to P&GP and the Expert Panel for review prior to publication'"
},
{
"ID": "157",
"agreement_id": "229",
"nct_id": "NCT00067470",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first publication of the results shall be made by Sponsor in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.'"
},
{
"ID": "158",
"agreement_id": "230",
"nct_id": "NCT00067808",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "159",
"agreement_id": "231",
"nct_id": "NCT00068107",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "160",
"agreement_id": "168",
"nct_id": "NCT00053014",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "161",
"agreement_id": "169",
"nct_id": "NCT00053365",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "162",
"agreement_id": "170",
"nct_id": "NCT00053417",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The INSTITUTION shall submit any such manuscript or release to the SPONSOR for comment prior to publication or release at least forty-five (45) days in advance of submission for publication. If the parties disagree concerning appropriateness of the data analysis and presentation, INSTITUTION agrees to meet with SPONSOR\u2019s representatives for the purpose of making good faith efforts to discuss and resolve any issues or disagreement.'"
},
{
"ID": "163",
"agreement_id": "171",
"nct_id": "NCT00053482",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications'"
},
{
"ID": "164",
"agreement_id": "172",
"nct_id": "NCT00019604",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "165",
"agreement_id": "173",
"nct_id": "NCT00019747",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "166",
"agreement_id": "70",
"nct_id": "NCT00003869",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "167",
"agreement_id": "71",
"nct_id": "NCT00003896",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "168",
"agreement_id": "72",
"nct_id": "NCT00003907",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "169",
"agreement_id": "73",
"nct_id": "NCT00003910",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "170",
"agreement_id": "74",
"nct_id": "NCT00004054",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "171",
"agreement_id": "75",
"nct_id": "NCT00004092",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "172",
"agreement_id": "76",
"nct_id": "NCT00004143",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "173",
"agreement_id": "77",
"nct_id": "NCT00004146",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "174",
"agreement_id": "78",
"nct_id": "NCT00004228",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "175",
"agreement_id": "79",
"nct_id": "NCT00025155",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "176",
"agreement_id": "80",
"nct_id": "NCT00025233",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "177",
"agreement_id": "81",
"nct_id": "NCT00025506",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "178",
"agreement_id": "82",
"nct_id": "NCT00025662",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "179",
"agreement_id": "193",
"nct_id": "NCT00057330",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "180",
"agreement_id": "194",
"nct_id": "NCT00057577",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "181",
"agreement_id": "195",
"nct_id": "NCT00057681",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "182",
"agreement_id": "196",
"nct_id": "NCT00057785",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "183",
"agreement_id": "197",
"nct_id": "NCT00057811",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "184",
"agreement_id": "198",
"nct_id": "NCT00057837",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "185",
"agreement_id": "199",
"nct_id": "NCT00057876",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "186",
"agreement_id": "200",
"nct_id": "NCT00057941",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "187",
"agreement_id": "201",
"nct_id": "NCT00057954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "188",
"agreement_id": "202",
"nct_id": "NCT00058019",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "189",
"agreement_id": "203",
"nct_id": "NCT00058214",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "190",
"agreement_id": "204",
"nct_id": "NCT00058539",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "191",
"agreement_id": "205",
"nct_id": "NCT00058552",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "192",
"agreement_id": "206",
"nct_id": "NCT00059215",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "193",
"agreement_id": "207",
"nct_id": "NCT00059332",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "194",
"agreement_id": "208",
"nct_id": "NCT00059475",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "195",
"agreement_id": "209",
"nct_id": "NCT00059839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "196",
"agreement_id": "210",
"nct_id": "NCT00060008",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "197",
"agreement_id": "211",
"nct_id": "NCT00060346",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "198",
"agreement_id": "212",
"nct_id": "NCT00060528",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "199",
"agreement_id": "213",
"nct_id": "NCT00060840",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "200",
"agreement_id": "214",
"nct_id": "NCT00060944",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "201",
"agreement_id": "215",
"nct_id": "NCT00061048",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "202",
"agreement_id": "216",
"nct_id": "NCT00061373",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "203",
"agreement_id": "217",
"nct_id": "NCT00061633",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "204",
"agreement_id": "232",
"nct_id": "NCT00068237",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "205",
"agreement_id": "233",
"nct_id": "NCT00068380",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "206",
"agreement_id": "234",
"nct_id": "NCT00068393",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "207",
"agreement_id": "235",
"nct_id": "NCT00068419",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "208",
"agreement_id": "236",
"nct_id": "NCT00068575",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "209",
"agreement_id": "237",
"nct_id": "NCT00068588",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "210",
"agreement_id": "238",
"nct_id": "NCT00068770",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "211",
"agreement_id": "239",
"nct_id": "NCT00068822",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "212",
"agreement_id": "240",
"nct_id": "NCT00069121",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "213",
"agreement_id": "241",
"nct_id": "NCT00069160",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "214",
"agreement_id": "242",
"nct_id": "NCT00069264",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "215",
"agreement_id": "243",
"nct_id": "NCT00069277",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "216",
"agreement_id": "244",
"nct_id": "NCT00069641",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "217",
"agreement_id": "245",
"nct_id": "NCT00069784",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "\u0022The Steering Committee will be responsible for preparing summaries of the study results for publication in the medical literature, and will have the right to submit such summaries for publication after a review by the sponsor. In such cases comments from the sponsor to the Steering Committee are to be provided within 15 working days. All comments will be carefully considered by the Steering Committee who nevertheless have the final decision on the content of the manuscript.\u0022'"
},
{
"ID": "218",
"agreement_id": "246",
"nct_id": "NCT00042991",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "219",
"agreement_id": "247",
"nct_id": "NCT00043186",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator\u2019s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "220",
"agreement_id": "248",
"nct_id": "NCT00043979",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "221",
"agreement_id": "249",
"nct_id": "NCT00044005",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "222",
"agreement_id": "250",
"nct_id": "NCT00044044",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "223",
"agreement_id": "251",
"nct_id": "NCT00044213",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Enrolling Centers must abide by all TACT and NIH conflict of interest policies. Decisions about authorship on all multi-center publications resulting from research under this agreement will be made by the TACT Publica\u00actions Committee prior to publication. No publications or other public disclosure shall be made until the TACT results are unblinded and results from all sites have been received and analyzed or TACT has been abandoned at all sites.'"
},
{
"ID": "224",
"agreement_id": "252",
"nct_id": "NCT00044512",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Agreement between Sponsor and PI should be reached before publication'"
},
{
"ID": "225",
"agreement_id": "253",
"nct_id": "NCT00044655",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "226",
"agreement_id": "254",
"nct_id": "NCT00045162",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "227",
"agreement_id": "255",
"nct_id": "NCT00045305",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "228",
"agreement_id": "256",
"nct_id": "NCT00045487",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "229",
"agreement_id": "218",
"nct_id": "NCT00061893",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "230",
"agreement_id": "219",
"nct_id": "NCT00061932",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "231",
"agreement_id": "220",
"nct_id": "NCT00066066",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "232",
"agreement_id": "221",
"nct_id": "NCT00066170",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "233",
"agreement_id": "222",
"nct_id": "NCT00066222",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "234",
"agreement_id": "223",
"nct_id": "NCT00066365",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "235",
"agreement_id": "224",
"nct_id": "NCT00066469",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "236",
"agreement_id": "225",
"nct_id": "NCT00066573",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "237",
"agreement_id": "226",
"nct_id": "NCT00066742",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "238",
"agreement_id": "353",
"nct_id": "NCT00062751",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "239",
"agreement_id": "354",
"nct_id": "NCT00062764",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "240",
"agreement_id": "317",
"nct_id": "NCT00073307",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The agreed point of publication is 12-18 months after database lock at the earliest.'"
},
{
"ID": "241",
"agreement_id": "Bayer will have up to 30\/45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "242",
"agreement_id": "No publication of single center data should be done prior of publication if multi -center data.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "243",
"agreement_id": "318",
"nct_id": "NCT00073333",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "244",
"agreement_id": "319",
"nct_id": "NCT00073528",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "245",
"agreement_id": "320",
"nct_id": "NCT00073983",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "246",
"agreement_id": "321",
"nct_id": "NCT00074152",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "247",
"agreement_id": "322",
"nct_id": "NCT00074165",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "248",
"agreement_id": "323",
"nct_id": "NCT00074269",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "249",
"agreement_id": "324",
"nct_id": "NCT00074412",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) & company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review & comment. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts & five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "250",
"agreement_id": "325",
"nct_id": "NCT00074815",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "251",
"agreement_id": "174",
"nct_id": "NCT00020722",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "252",
"agreement_id": "175",
"nct_id": "NCT00021229",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "253",
"agreement_id": "176",
"nct_id": "NCT00021541",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "254",
"agreement_id": "177",
"nct_id": "NCT00022490",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "255",
"agreement_id": "178",
"nct_id": "NCT00022659",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "256",
"agreement_id": "179",
"nct_id": "NCT00022672",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "257",
"agreement_id": "180",
"nct_id": "NCT00023309",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "258",
"agreement_id": "181",
"nct_id": "NCT00023322",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "259",
"agreement_id": "182",
"nct_id": "NCT00023452",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "260",
"agreement_id": "183",
"nct_id": "NCT00023673",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "261",
"agreement_id": "184",
"nct_id": "NCT00023712",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "262",
"agreement_id": "185",
"nct_id": "NCT00023764",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "263",
"agreement_id": "186",
"nct_id": "NCT00024102",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "264",
"agreement_id": "187",
"nct_id": "NCT00056407",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "265",
"agreement_id": "188",
"nct_id": "NCT00056472",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "266",
"agreement_id": "189",
"nct_id": "NCT00056498",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "267",
"agreement_id": "190",
"nct_id": "NCT00056550",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "268",
"agreement_id": "191",
"nct_id": "NCT00056563",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "269",
"agreement_id": "192",
"nct_id": "NCT00056862",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "270",
"agreement_id": "270",
"nct_id": "NCT00048568",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "271",
"agreement_id": "271",
"nct_id": "NCT00053495",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.'"
},
{
"ID": "272",
"agreement_id": "272",
"nct_id": "NCT00053703",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "273",
"agreement_id": "273",
"nct_id": "NCT00053846",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "274",
"agreement_id": "274",
"nct_id": "NCT00054028",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "275",
"agreement_id": "275",
"nct_id": "NCT00054275",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "276",
"agreement_id": "276",
"nct_id": "NCT00054327",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "277",
"agreement_id": "277",
"nct_id": "NCT00054639",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "278",
"agreement_id": "278",
"nct_id": "NCT00054665",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "279",
"agreement_id": "279",
"nct_id": "NCT00054691",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "280",
"agreement_id": "280",
"nct_id": "NCT00054717",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "281",
"agreement_id": "281",
"nct_id": "NCT00054847",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "282",
"agreement_id": "282",
"nct_id": "NCT00055237",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "283",
"agreement_id": "293",
"nct_id": "NCT00084084",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Shire's agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period \u2264 180 days from the time submitted to Shire for review. Shire does not prohibit publication but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial's multi-center publication.'"
},
{
"ID": "284",
"agreement_id": "294",
"nct_id": "NCT00084136",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights'"
},
{
"ID": "285",
"agreement_id": "295",
"nct_id": "NCT00084266",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "286",
"agreement_id": "296",
"nct_id": "NCT00084383",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "287",
"agreement_id": "297",
"nct_id": "NCT00084409",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "288",
"agreement_id": "298",
"nct_id": "NCT00084487",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "289",
"agreement_id": "299",
"nct_id": "NCT00071058",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "290",
"agreement_id": "300",
"nct_id": "NCT00071110",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "291",
"agreement_id": "301",
"nct_id": "NCT00071396",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "292",
"agreement_id": "302",
"nct_id": "NCT00071487",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "293",
"agreement_id": "303",
"nct_id": "NCT00071721",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "294",
"agreement_id": "304",
"nct_id": "NCT00071760",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "295",
"agreement_id": "305",
"nct_id": "NCT00071799",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.'"
},
{
"ID": "296",
"agreement_id": "306",
"nct_id": "NCT00071812",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "For multi-center trials, no investigator will be authorized to publish study results from an individual center until the multi-center trial results are published. All manuscripts and abstracts must be submitted to the sponsor for review at least 30 days prior to submission for publication or for presentation at a scientific meeting. Proposed abstracts and publications will be reviewed promptly.'"
},
{
"ID": "297",
"agreement_id": "307",
"nct_id": "NCT00071890",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review results communications prior to public release and can embargo communications regarding trial results with no delay specified'"
},
{
"ID": "298",
"agreement_id": "308",
"nct_id": "NCT00071981",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "299",
"agreement_id": "309",
"nct_id": "NCT00072176",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "300",
"agreement_id": "310",
"nct_id": "NCT00072189",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "301",
"agreement_id": "311",
"nct_id": "NCT00072280",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "302",
"agreement_id": "312",
"nct_id": "NCT00072449",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "303",
"agreement_id": "313",
"nct_id": "NCT00072475",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "304",
"agreement_id": "314",
"nct_id": "NCT00072566",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "305",
"agreement_id": "315",
"nct_id": "NCT00073008",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "306",
"agreement_id": "316",
"nct_id": "NCT00073021",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "307",
"agreement_id": "329",
"nct_id": "NCT00075218",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "308",
"agreement_id": "330",
"nct_id": "NCT00075270",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "309",
"agreement_id": "331",
"nct_id": "NCT00075400",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "310",
"agreement_id": "332",
"nct_id": "NCT00075478",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "311",
"agreement_id": "333",
"nct_id": "NCT00075582",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "312",
"agreement_id": "334",
"nct_id": "NCT00075725",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval'"
},
{
"ID": "313",
"agreement_id": "335",
"nct_id": "NCT00075803",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "314",
"agreement_id": "336",
"nct_id": "NCT00075881",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "315",
"agreement_id": "337",
"nct_id": "NCT00075946",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "316",
"agreement_id": "338",
"nct_id": "NCT00076011",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "317",
"agreement_id": "339",
"nct_id": "NCT00076024",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "318",
"agreement_id": "340",
"nct_id": "NCT00069823",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "319",
"agreement_id": "341",
"nct_id": "NCT00069953",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "320",
"agreement_id": "342",
"nct_id": "NCT00070018",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "321",
"agreement_id": "343",
"nct_id": "NCT00070109",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "322",
"agreement_id": "344",
"nct_id": "NCT00070291",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "323",
"agreement_id": "345",
"nct_id": "NCT00070499",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "324",
"agreement_id": "346",
"nct_id": "NCT00071006",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "325",
"agreement_id": "347",
"nct_id": "NCT00071032",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "326",
"agreement_id": "348",
"nct_id": "NCT00061945",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "327",
"agreement_id": "349",
"nct_id": "NCT00062010",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "328",
"agreement_id": "350",
"nct_id": "NCT00062439",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "329",
"agreement_id": "351",
"nct_id": "NCT00062647",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "330",
"agreement_id": "352",
"nct_id": "NCT00062738",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "331",
"agreement_id": "434",
"nct_id": "NCT00087139",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "332",
"agreement_id": "435",
"nct_id": "NCT00087152",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "333",
"agreement_id": "436",
"nct_id": "NCT00087438",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "334",
"agreement_id": "437",
"nct_id": "NCT00087490",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "335",
"agreement_id": "438",
"nct_id": "NCT00087516",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "336",
"agreement_id": "439",
"nct_id": "NCT00087529",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "337",
"agreement_id": "440",
"nct_id": "NCT00087555",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "338",
"agreement_id": "441",
"nct_id": "NCT00087633",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "339",
"agreement_id": "405",
"nct_id": "NCT00081497",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, Principal Investigator (PI) can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "340",
"agreement_id": "406",
"nct_id": "NCT00081653",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "341",
"agreement_id": "407",
"nct_id": "NCT00081731",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "342",
"agreement_id": "326",
"nct_id": "NCT00074958",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "343",
"agreement_id": "327",
"nct_id": "NCT00074984",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "344",
"agreement_id": "328",
"nct_id": "NCT00075088",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "345",
"agreement_id": "283",
"nct_id": "NCT00055471",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "346",
"agreement_id": "284",
"nct_id": "NCT00055497",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Abbott requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. Abbott requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if Abbott needs to secure patent or proprietary protection.'"
},
{
"ID": "347",
"agreement_id": "285",
"nct_id": "NCT00056160",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present the clinical data generated from the study provided that such Investigator shall furnish sponsor with a copy of the proposed publication or presentation at least 60 days in advance of submission, delete any confidential information, and delay submission for up to 90 days to permit the preparation and filing of appropriate intellectual property applications.'"
},
{
"ID": "348",
"agreement_id": "286",
"nct_id": "NCT00056316",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "349",
"agreement_id": "287",
"nct_id": "NCT00083551",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "350",
"agreement_id": "288",
"nct_id": "NCT00083616",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "351",
"agreement_id": "289",
"nct_id": "NCT00083720",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Investigators may not independently publish\/disclose any study data, findings or conclusions except as part of an overall multi-center publication. After final publication, or if a draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to review for sponsor confidential information which may be redacted at sponsor request. Publication may be delayed up to 90 days to seek patent protection.'"
},
{
"ID": "352",
"agreement_id": "290",
"nct_id": "NCT00083759",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor will have at least 30 days to request revisions to a proposed Publication. Institution will delete any Confidential Information provided by Sponsor, will delay Publication submission for a further 90 days for the filing of patent applications, and will not issue a press release about the Study without the Sponsor\u2019s prior written consent.'"
},
{
"ID": "353",
"agreement_id": "291",
"nct_id": "NCT00083889",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "354",
"agreement_id": "292",
"nct_id": "NCT00083915",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "355",
"agreement_id": "257",
"nct_id": "NCT00045630",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "356",
"agreement_id": "258",
"nct_id": "NCT00046228",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "357",
"agreement_id": "259",
"nct_id": "NCT00046475",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "358",
"agreement_id": "260",
"nct_id": "NCT00046839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "359",
"agreement_id": "261",
"nct_id": "NCT00046891",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "360",
"agreement_id": "262",
"nct_id": "NCT00046930",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "361",
"agreement_id": "263",
"nct_id": "NCT00047008",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "362",
"agreement_id": "264",
"nct_id": "NCT00047320",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "363",
"agreement_id": "265",
"nct_id": "NCT00047385",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "364",
"agreement_id": "266",
"nct_id": "NCT00047463",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "365",
"agreement_id": "267",
"nct_id": "NCT00047879",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "366",
"agreement_id": "268",
"nct_id": "NCT00048347",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "367",
"agreement_id": "269",
"nct_id": "NCT00048542",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Abbott requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. Abbott requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if Abbott needs to secure patent or proprietary protection.'"
},
{
"ID": "368",
"agreement_id": "380",
"nct_id": "NCT00081861",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "369",
"agreement_id": "381",
"nct_id": "NCT00082017",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "370",
"agreement_id": "382",
"nct_id": "NCT00082173",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "371",
"agreement_id": "383",
"nct_id": "NCT00082329",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "372",
"agreement_id": "384",
"nct_id": "NCT00082342",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "373",
"agreement_id": "385",
"nct_id": "NCT00082355",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "374",
"agreement_id": "386",
"nct_id": "NCT00082368",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "375",
"agreement_id": "387",
"nct_id": "NCT00082381",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "376",
"agreement_id": "388",
"nct_id": "NCT00082407",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "377",
"agreement_id": "389",
"nct_id": "NCT00082433",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "378",
"agreement_id": "390",
"nct_id": "NCT00082758",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "379",
"agreement_id": "391",
"nct_id": "NCT00082810",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "380",
"agreement_id": "392",
"nct_id": "NCT00082888",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "381",
"agreement_id": "393",
"nct_id": "NCT00083122",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "382",
"agreement_id": "394",
"nct_id": "NCT00083174",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "383",
"agreement_id": "395",
"nct_id": "NCT00083226",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "384",
"agreement_id": "396",
"nct_id": "NCT00083382",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "385",
"agreement_id": "397",
"nct_id": "NCT00080483",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "386",
"agreement_id": "398",
"nct_id": "NCT00080535",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "387",
"agreement_id": "399",
"nct_id": "NCT00080899",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "388",
"agreement_id": "400",
"nct_id": "NCT00080912",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "389",
"agreement_id": "401",
"nct_id": "NCT00080938",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "390",
"agreement_id": "402",
"nct_id": "NCT00081289",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "391",
"agreement_id": "403",
"nct_id": "NCT00081328",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "This work was conducted by a collaborative group. All investigators in the study group adhere to the Publications & Presentations Policy. The policy spells out procedures for proposing, developing, and submitting publications and presentations using study data. Once results have been published or presented, all members of the study group are free to discuss them.'"
},
{
"ID": "392",
"agreement_id": "404",
"nct_id": "NCT00081458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "393",
"agreement_id": "417",
"nct_id": "NCT00085644",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Abbott requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. Abbott requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if Abbott needs to secure patent or proprietary protection.'"
},
{
"ID": "394",
"agreement_id": "418",
"nct_id": "NCT00085709",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "395",
"agreement_id": "419",
"nct_id": "NCT00085839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "396",
"agreement_id": "420",
"nct_id": "NCT00085917",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "397",
"agreement_id": "421",
"nct_id": "NCT00086047",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "398",
"agreement_id": "422",
"nct_id": "NCT00086190",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "399",
"agreement_id": "423",
"nct_id": "NCT00086281",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "400",
"agreement_id": "424",
"nct_id": "NCT00086307",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "401",
"agreement_id": "425",
"nct_id": "NCT00086346",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "402",
"agreement_id": "426",
"nct_id": "NCT00086385",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "403",
"agreement_id": "427",
"nct_id": "NCT00086411",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "404",
"agreement_id": "428",
"nct_id": "NCT00086502",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "405",
"agreement_id": "429",
"nct_id": "NCT00086515",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "406",
"agreement_id": "430",
"nct_id": "NCT00086580",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after an independent multi-investigator publication (in which the PI can participate) or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "407",
"agreement_id": "431",
"nct_id": "NCT00086619",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "408",
"agreement_id": "432",
"nct_id": "NCT00086684",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "409",
"agreement_id": "433",
"nct_id": "NCT00086996",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "410",
"agreement_id": "519",
"nct_id": "NCT00101868",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "411",
"agreement_id": "520",
"nct_id": "NCT00101907",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "412",
"agreement_id": "521",
"nct_id": "NCT00101933",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 60 days.'"
},
{
"ID": "413",
"agreement_id": "522",
"nct_id": "NCT00102063",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "414",
"agreement_id": "523",
"nct_id": "NCT00102440",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "415",
"agreement_id": "524",
"nct_id": "NCT00102518",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "416",
"agreement_id": "525",
"nct_id": "NCT00102596",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "417",
"agreement_id": "526",
"nct_id": "NCT00102687",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present study data provided that the investigator shall (i)furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.'"
},
{
"ID": "418",
"agreement_id": "527",
"nct_id": "NCT00102804",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "419",
"agreement_id": "528",
"nct_id": "NCT00103012",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "420",
"agreement_id": "408",
"nct_id": "NCT00081770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "421",
"agreement_id": "409",
"nct_id": "NCT00084617",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "422",
"agreement_id": "410",
"nct_id": "NCT00084682",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "423",
"agreement_id": "411",
"nct_id": "NCT00085098",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "424",
"agreement_id": "412",
"nct_id": "NCT00085202",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "425",
"agreement_id": "413",
"nct_id": "NCT00085293",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "426",
"agreement_id": "414",
"nct_id": "NCT00085423",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "427",
"agreement_id": "415",
"nct_id": "NCT00085436",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "428",
"agreement_id": "416",
"nct_id": "NCT00085631",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "429",
"agreement_id": "355",
"nct_id": "NCT00063154",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "430",
"agreement_id": "356",
"nct_id": "NCT00063232",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "431",
"agreement_id": "357",
"nct_id": "NCT00063258",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "432",
"agreement_id": "358",
"nct_id": "NCT00063362",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "433",
"agreement_id": "359",
"nct_id": "NCT00063570",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "434",
"agreement_id": "360",
"nct_id": "NCT00063622",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "435",
"agreement_id": "361",
"nct_id": "NCT00063635",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "436",
"agreement_id": "362",
"nct_id": "NCT00063934",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "437",
"agreement_id": "363",
"nct_id": "NCT00063986",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "438",
"agreement_id": "364",
"nct_id": "NCT00064025",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "439",
"agreement_id": "365",
"nct_id": "NCT00064038",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "440",
"agreement_id": "366",
"nct_id": "NCT00064259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "441",
"agreement_id": "367",
"nct_id": "NCT00064350",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "442",
"agreement_id": "368",
"nct_id": "NCT00064662",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "443",
"agreement_id": "369",
"nct_id": "NCT00064701",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institute and\/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or until 18 months have elapsed following study completion. Sponsor must receive a site\u2019s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.'"
},
{
"ID": "444",
"agreement_id": "370",
"nct_id": "NCT00064792",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "445",
"agreement_id": "371",
"nct_id": "NCT00064844",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "446",
"agreement_id": "372",
"nct_id": "NCT00065065",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "447",
"agreement_id": "373",
"nct_id": "NCT00065156",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Unless approved by Celgene, single center data will not be published before multicenter data, unless more than 1 year has elapsed since completion of the Study. Thereafter, Investigator may publish single center data provided that Investigator shall: i) provide a copy of the publication to Celgene at least 60 days in advance of submission for publication; ii) delete Celgene Confidential Information and; iii) delay submission up to 90 additional days to permit intellectual property filings.'"
},
{
"ID": "448",
"agreement_id": "374",
"nct_id": "NCT00065429",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "449",
"agreement_id": "375",
"nct_id": "NCT00065442",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.'"
},
{
"ID": "450",
"agreement_id": "376",
"nct_id": "NCT00065468",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "451",
"agreement_id": "377",
"nct_id": "NCT00065507",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "452",
"agreement_id": "378",
"nct_id": "NCT00065611",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "453",
"agreement_id": "379",
"nct_id": "NCT00065806",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PIs agree to follow the CARRA Publication Guidelines. https:\/\/www.carragroup.org\/about-carra\/carra-policies\/carra-endorsed-studies-policies'"
},
{
"ID": "454",
"agreement_id": "455",
"nct_id": "NCT00076245",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "455",
"agreement_id": "456",
"nct_id": "NCT00076336",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "456",
"agreement_id": "457",
"nct_id": "NCT00076570",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "457",
"agreement_id": "458",
"nct_id": "NCT00076687",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "458",
"agreement_id": "459",
"nct_id": "NCT00076752",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "459",
"agreement_id": "460",
"nct_id": "NCT00076804",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "460",
"agreement_id": "461",
"nct_id": "NCT00076999",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "461",
"agreement_id": "462",
"nct_id": "NCT00077207",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "462",
"agreement_id": "463",
"nct_id": "NCT00077376",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "463",
"agreement_id": "464",
"nct_id": "NCT00077675",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "464",
"agreement_id": "465",
"nct_id": "NCT00077857",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "465",
"agreement_id": "466",
"nct_id": "NCT00077922",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "466",
"agreement_id": "479",
"nct_id": "NCT00079040",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "467",
"agreement_id": "480",
"nct_id": "NCT00079274",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "468",
"agreement_id": "481",
"nct_id": "NCT00079326",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "469",
"agreement_id": "482",
"nct_id": "NCT00079339",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "470",
"agreement_id": "483",
"nct_id": "NCT00079391",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "471",
"agreement_id": "484",
"nct_id": "NCT00079417",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "472",
"agreement_id": "485",
"nct_id": "NCT00079677",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "473",
"agreement_id": "486",
"nct_id": "NCT00079781",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Each Investigator, Coordinator, and Institution agree to submit publications to the RNS\u00ae System Study Publication Committee for review prior to submission for publication (at least 30 days for manuscripts and at least 7 days for abstracts) to assure that publication does not compromise the scientific integrity of the study or contain confidential NeuroPace information. NeuroPace may require that presentation\/publication be withheld for up to 60 days to allow for filing of a patent application.'"
},
{
"ID": "474",
"agreement_id": "487",
"nct_id": "NCT00079937",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.'"
},
{
"ID": "475",
"agreement_id": "488",
"nct_id": "NCT00080119",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "476",
"agreement_id": "489",
"nct_id": "NCT00080288",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "477",
"agreement_id": "490",
"nct_id": "NCT00080301",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "478",
"agreement_id": "491",
"nct_id": "NCT00080470",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "479",
"agreement_id": "492",
"nct_id": "NCT00091026",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "480",
"agreement_id": "493",
"nct_id": "NCT00091273",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "481",
"agreement_id": "494",
"nct_id": "NCT00091390",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.'"
},
{
"ID": "482",
"agreement_id": "495",
"nct_id": "NCT00091442",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission. Expedited reviews will be arranged if needed. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application. The sponsor will not mandate modifications to scientific content and does not have the right to suppress information.'"
},
{
"ID": "483",
"agreement_id": "496",
"nct_id": "NCT00091507",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "484",
"agreement_id": "497",
"nct_id": "NCT00091572",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "485",
"agreement_id": "498",
"nct_id": "NCT00091793",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "486",
"agreement_id": "499",
"nct_id": "NCT00091819",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "487",
"agreement_id": "500",
"nct_id": "NCT00091832",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator\u2019s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "488",
"agreement_id": "501",
"nct_id": "NCT00100698",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "489",
"agreement_id": "514",
"nct_id": "NCT00101582",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "490",
"agreement_id": "515",
"nct_id": "NCT00101647",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "491",
"agreement_id": "516",
"nct_id": "NCT00101660",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "492",
"agreement_id": "517",
"nct_id": "NCT00101686",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "493",
"agreement_id": "518",
"nct_id": "NCT00101816",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "494",
"agreement_id": "590",
"nct_id": "NCT00090987",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "495",
"agreement_id": "591",
"nct_id": "NCT00096993",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "496",
"agreement_id": "592",
"nct_id": "NCT00097253",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "497",
"agreement_id": "593",
"nct_id": "NCT00097448",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "498",
"agreement_id": "594",
"nct_id": "NCT00097500",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "499",
"agreement_id": "595",
"nct_id": "NCT00097591",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "500",
"agreement_id": "596",
"nct_id": "NCT00097695",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "501",
"agreement_id": "597",
"nct_id": "NCT00097708",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "502",
"agreement_id": "598",
"nct_id": "NCT00097721",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "503",
"agreement_id": "599",
"nct_id": "NCT00097773",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "504",
"agreement_id": "600",
"nct_id": "NCT00097786",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "505",
"agreement_id": "529",
"nct_id": "NCT00093379",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "506",
"agreement_id": "530",
"nct_id": "NCT00093496",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "507",
"agreement_id": "531",
"nct_id": "NCT00093756",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "508",
"agreement_id": "532",
"nct_id": "NCT00093847",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "509",
"agreement_id": "533",
"nct_id": "NCT00094055",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "510",
"agreement_id": "534",
"nct_id": "NCT00094094",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "511",
"agreement_id": "502",
"nct_id": "NCT00100789",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "512",
"agreement_id": "503",
"nct_id": "NCT00100841",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "513",
"agreement_id": "504",
"nct_id": "NCT00100932",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "514",
"agreement_id": "505",
"nct_id": "NCT00101036",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "515",
"agreement_id": "506",
"nct_id": "NCT00101101",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "516",
"agreement_id": "507",
"nct_id": "NCT00101166",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "517",
"agreement_id": "508",
"nct_id": "NCT00101192",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "518",
"agreement_id": "509",
"nct_id": "NCT00101283",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "519",
"agreement_id": "510",
"nct_id": "NCT00101361",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "520",
"agreement_id": "511",
"nct_id": "NCT00101400",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "521",
"agreement_id": "512",
"nct_id": "NCT00101413",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "522",
"agreement_id": "513",
"nct_id": "NCT00101452",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "523",
"agreement_id": "467",
"nct_id": "NCT00077974",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "524",
"agreement_id": "468",
"nct_id": "NCT00078286",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "525",
"agreement_id": "469",
"nct_id": "NCT00078312",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "526",
"agreement_id": "470",
"nct_id": "NCT00078325",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "527",
"agreement_id": "471",
"nct_id": "NCT00078377",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "528",
"agreement_id": "472",
"nct_id": "NCT00078403",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve US or foreign patent or other intellectual property rights.'"
},
{
"ID": "529",
"agreement_id": "473",
"nct_id": "NCT00078559",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "530",
"agreement_id": "474",
"nct_id": "NCT00078715",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "531",
"agreement_id": "475",
"nct_id": "NCT00078728",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "532",
"agreement_id": "476",
"nct_id": "NCT00078754",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "533",
"agreement_id": "477",
"nct_id": "NCT00078949",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "534",
"agreement_id": "478",
"nct_id": "NCT00079001",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "535",
"agreement_id": "442",
"nct_id": "NCT00087672",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "536",
"agreement_id": "443",
"nct_id": "NCT00087698",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "537",
"agreement_id": "444",
"nct_id": "NCT00088153",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "538",
"agreement_id": "445",
"nct_id": "NCT00088166",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "539",
"agreement_id": "446",
"nct_id": "NCT00088218",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "540",
"agreement_id": "447",
"nct_id": "NCT00088374",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "541",
"agreement_id": "448",
"nct_id": "NCT00088465",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "542",
"agreement_id": "449",
"nct_id": "NCT00088595",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "543",
"agreement_id": "450",
"nct_id": "NCT00088621",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "544",
"agreement_id": "451",
"nct_id": "NCT00088634",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "545",
"agreement_id": "452",
"nct_id": "NCT00088881",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "546",
"agreement_id": "453",
"nct_id": "NCT00076102",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "547",
"agreement_id": "454",
"nct_id": "NCT00076219",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "548",
"agreement_id": "557",
"nct_id": "NCT00093145",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Sponsor a copy of the manuscript at least 30 days prior to submission; if no response is received within 30 days the publication or presentation may proceed without delay. Sponsor may request that Confidential Information be deleted. Publication may be delayed for an additional 60 days if patentable matter is included.'"
},
{
"ID": "549",
"agreement_id": "558",
"nct_id": "NCT00089141",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "550",
"agreement_id": "559",
"nct_id": "NCT00089297",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "551",
"agreement_id": "560",
"nct_id": "NCT00089479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "552",
"agreement_id": "561",
"nct_id": "NCT00089505",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "553",
"agreement_id": "562",
"nct_id": "NCT00089544",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "554",
"agreement_id": "563",
"nct_id": "NCT00089583",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "555",
"agreement_id": "564",
"nct_id": "NCT00089609",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "556",
"agreement_id": "565",
"nct_id": "NCT00089635",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator\u2019s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "557",
"agreement_id": "566",
"nct_id": "NCT00089648",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "558",
"agreement_id": "567",
"nct_id": "NCT00089661",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "559",
"agreement_id": "568",
"nct_id": "NCT00089674",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "560",
"agreement_id": "569",
"nct_id": "NCT00089778",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "561",
"agreement_id": "570",
"nct_id": "NCT00089791",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "562",
"agreement_id": "571",
"nct_id": "NCT00089843",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "563",
"agreement_id": "572",
"nct_id": "NCT00089895",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "564",
"agreement_id": "573",
"nct_id": "NCT00089999",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "565",
"agreement_id": "574",
"nct_id": "NCT00090051",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "566",
"agreement_id": "575",
"nct_id": "NCT00090103",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "567",
"agreement_id": "576",
"nct_id": "NCT00090142",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "568",
"agreement_id": "577",
"nct_id": "NCT00090220",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication or presentation'"
},
{
"ID": "569",
"agreement_id": "662",
"nct_id": "NCT00096018",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "570",
"agreement_id": "663",
"nct_id": "NCT00096031",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "571",
"agreement_id": "664",
"nct_id": "NCT00096122",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "572",
"agreement_id": "665",
"nct_id": "NCT00096135",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior sponsor approval.'"
},
{
"ID": "573",
"agreement_id": "666",
"nct_id": "NCT00096174",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "574",
"agreement_id": "667",
"nct_id": "NCT00096200",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "575",
"agreement_id": "668",
"nct_id": "NCT00096226",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "576",
"agreement_id": "669",
"nct_id": "NCT00096265",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "577",
"agreement_id": "670",
"nct_id": "NCT00096278",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "578",
"agreement_id": "683",
"nct_id": "NCT00107575",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "579",
"agreement_id": "684",
"nct_id": "NCT00107614",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "580",
"agreement_id": "685",
"nct_id": "NCT00107783",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "581",
"agreement_id": "601",
"nct_id": "NCT00097981",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "582",
"agreement_id": "602",
"nct_id": "NCT00098059",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "583",
"agreement_id": "603",
"nct_id": "NCT00098254",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "584",
"agreement_id": "604",
"nct_id": "NCT00098293",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "585",
"agreement_id": "605",
"nct_id": "NCT00098306",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "586",
"agreement_id": "606",
"nct_id": "NCT00098345",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "587",
"agreement_id": "607",
"nct_id": "NCT00098475",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "588",
"agreement_id": "608",
"nct_id": "NCT00098670",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "589",
"agreement_id": "609",
"nct_id": "NCT00098722",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "590",
"agreement_id": "610",
"nct_id": "NCT00098748",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "591",
"agreement_id": "611",
"nct_id": "NCT00098774",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "592",
"agreement_id": "612",
"nct_id": "NCT00098787",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "593",
"agreement_id": "578",
"nct_id": "NCT00090233",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "594",
"agreement_id": "579",
"nct_id": "NCT00090259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "595",
"agreement_id": "580",
"nct_id": "NCT00090285",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.'"
},
{
"ID": "596",
"agreement_id": "581",
"nct_id": "NCT00090363",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "AstraZeneca can review results communications prior to public release and may within 30 days of receipt require that submission or disclosure be delayed for up to 2 months in order to file patent applications. AstraZeneca can also, within 30 days of receipt, require amendments to be made in order to protect its patent and \/ or corporate interests.'"
},
{
"ID": "597",
"agreement_id": "582",
"nct_id": "NCT00090402",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "598",
"agreement_id": "583",
"nct_id": "NCT00090493",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "599",
"agreement_id": "584",
"nct_id": "NCT00090545",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "600",
"agreement_id": "585",
"nct_id": "NCT00090584",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "601",
"agreement_id": "586",
"nct_id": "NCT00090610",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "602",
"agreement_id": "587",
"nct_id": "NCT00090753",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights'"
},
{
"ID": "603",
"agreement_id": "588",
"nct_id": "NCT00090779",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights\u201d.'"
},
{
"ID": "604",
"agreement_id": "589",
"nct_id": "NCT00090844",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "605",
"agreement_id": "535",
"nct_id": "NCT00094107",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "606",
"agreement_id": "536",
"nct_id": "NCT00094172",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "607",
"agreement_id": "537",
"nct_id": "NCT00094302",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "608",
"agreement_id": "538",
"nct_id": "NCT00094328",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI agrees to collaborate with AstraZeneca on the contents and formation of any publication or disclosure and to pay due consideration to comments and opinions offered. AstraZeneca have 60 days for final manuscript review and may require that submission for publication be delayed for a further 90 days in order to file patent applications.'"
},
{
"ID": "609",
"agreement_id": "539",
"nct_id": "NCT00094458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "610",
"agreement_id": "540",
"nct_id": "NCT00094575",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "611",
"agreement_id": "541",
"nct_id": "NCT00094653",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "612",
"agreement_id": "542",
"nct_id": "NCT00088907",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "613",
"agreement_id": "543",
"nct_id": "NCT00088972",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "614",
"agreement_id": "544",
"nct_id": "NCT00089076",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "615",
"agreement_id": "545",
"nct_id": "NCT00092118",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "616",
"agreement_id": "546",
"nct_id": "NCT00092131",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "617",
"agreement_id": "547",
"nct_id": "NCT00092417",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "618",
"agreement_id": "548",
"nct_id": "NCT00092443",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "619",
"agreement_id": "549",
"nct_id": "NCT00092456",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "620",
"agreement_id": "550",
"nct_id": "NCT00092495",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "621",
"agreement_id": "551",
"nct_id": "NCT00092521",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "622",
"agreement_id": "552",
"nct_id": "NCT00092534",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "623",
"agreement_id": "553",
"nct_id": "NCT00092547",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "624",
"agreement_id": "554",
"nct_id": "NCT00092677",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "625",
"agreement_id": "555",
"nct_id": "NCT00093015",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "626",
"agreement_id": "556",
"nct_id": "NCT00093041",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "627",
"agreement_id": "625",
"nct_id": "NCT00100230",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "628",
"agreement_id": "626",
"nct_id": "NCT00100659",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "629",
"agreement_id": "627",
"nct_id": "NCT00103142",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "630",
"agreement_id": "628",
"nct_id": "NCT00103194",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "631",
"agreement_id": "629",
"nct_id": "NCT00103207",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "632",
"agreement_id": "630",
"nct_id": "NCT00103259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "633",
"agreement_id": "631",
"nct_id": "NCT00103311",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "634",
"agreement_id": "632",
"nct_id": "NCT00103506",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.'"
},
{
"ID": "635",
"agreement_id": "633",
"nct_id": "NCT00103610",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "636",
"agreement_id": "634",
"nct_id": "NCT00103662",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "637",
"agreement_id": "635",
"nct_id": "NCT00103740",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "638",
"agreement_id": "636",
"nct_id": "NCT00103844",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "639",
"agreement_id": "648",
"nct_id": "NCT00094900",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "640",
"agreement_id": "649",
"nct_id": "NCT00095056",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "641",
"agreement_id": "650",
"nct_id": "NCT00095121",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication must include results in their entirety and not as individual center data. Results may be published\/presented at scientific meetings. All manuscripts\/abstracts must be submitted to Gilead prior to submission. Any formal publication of the study in which input of Gilead personnel exceeded that of conventional monitoring will be considered as a joint publication by the investigator and the appropriate Gilead personnel.'"
},
{
"ID": "642",
"agreement_id": "651",
"nct_id": "NCT00095147",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "643",
"agreement_id": "652",
"nct_id": "NCT00095199",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "644",
"agreement_id": "653",
"nct_id": "NCT00095212",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "645",
"agreement_id": "654",
"nct_id": "NCT00095238",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "646",
"agreement_id": "655",
"nct_id": "NCT00095303",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "647",
"agreement_id": "656",
"nct_id": "NCT00095498",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "648",
"agreement_id": "657",
"nct_id": "NCT00095576",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "As this study is part of a multicenter trial, publications derived from this study should include input from the principal investigator, his\/her colleagues, the other investigators in this trial, and SPONSOR personnel.'"
},
{
"ID": "649",
"agreement_id": "The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. SPONSOR review can be expedited to meet publication guidelines.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "650",
"agreement_id": "658",
"nct_id": "NCT00095784",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "651",
"agreement_id": "659",
"nct_id": "NCT00095875",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "652",
"agreement_id": "660",
"nct_id": "NCT00095940",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "653",
"agreement_id": "661",
"nct_id": "NCT00095979",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "654",
"agreement_id": "739",
"nct_id": "NCT00104871",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "655",
"agreement_id": "740",
"nct_id": "NCT00105001",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "656",
"agreement_id": "741",
"nct_id": "NCT00105027",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "657",
"agreement_id": "742",
"nct_id": "NCT00105079",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "658",
"agreement_id": "743",
"nct_id": "NCT00105157",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "659",
"agreement_id": "744",
"nct_id": "NCT00105183",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Protocol: The 1st publication of study results shall be a complete, joint multicenter publication or disclosure coordinated by sponsor. Later publications will reference 1st publication.'"
},
{
"ID": "660",
"agreement_id": "Prior to submitting for publication, the Investigator shall allow sponsor at least 30 days to review the proposed Publication. Proposed Publications shall not include either Fresenius Biotech confidential information other than the study results or personal data on any patient, such as name or initials.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "661",
"agreement_id": "745",
"nct_id": "NCT00105196",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "662",
"agreement_id": "746",
"nct_id": "NCT00105235",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "663",
"agreement_id": "747",
"nct_id": "NCT00105443",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "664",
"agreement_id": "748",
"nct_id": "NCT00105469",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and Principal Investigator shall not publish, present or use any data or results arising out of the performance of this study for their own instruction, research or publication without the prior express written consent of Sponsor.'"
},
{
"ID": "665",
"agreement_id": "686",
"nct_id": "NCT00107900",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site\u2019s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.'"
},
{
"ID": "666",
"agreement_id": "687",
"nct_id": "NCT00107952",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "667",
"agreement_id": "688",
"nct_id": "NCT00107978",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "668",
"agreement_id": "689",
"nct_id": "NCT00107991",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "669",
"agreement_id": "690",
"nct_id": "NCT00108069",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "670",
"agreement_id": "691",
"nct_id": "NCT00108082",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "671",
"agreement_id": "692",
"nct_id": "NCT00108160",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "672",
"agreement_id": "693",
"nct_id": "NCT00108277",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "673",
"agreement_id": "694",
"nct_id": "NCT00108342",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "674",
"agreement_id": "695",
"nct_id": "NCT00108355",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "675",
"agreement_id": "696",
"nct_id": "NCT00108433",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "676",
"agreement_id": "697",
"nct_id": "NCT00108524",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "677",
"agreement_id": "698",
"nct_id": "NCT00108550",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "678",
"agreement_id": "699",
"nct_id": "NCT00108628",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "679",
"agreement_id": "700",
"nct_id": "NCT00108732",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "680",
"agreement_id": "701",
"nct_id": "NCT00108862",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "681",
"agreement_id": "702",
"nct_id": "NCT00108953",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The institution of the Coordinating Investigator (CI) has the right, consistent with academic standards, to publish any proposed publication written by the consultant as part of their services under this agreement. If the sponsor believes that any proposed publication contained any confidential information, the sponsor shall notify the CI, and the CI shall remove such confidential information.'"
},
{
"ID": "682",
"agreement_id": "703",
"nct_id": "NCT00109005",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "683",
"agreement_id": "704",
"nct_id": "NCT00109031",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "684",
"agreement_id": "705",
"nct_id": "NCT00109343",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "685",
"agreement_id": "706",
"nct_id": "NCT00109473",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "686",
"agreement_id": "707",
"nct_id": "NCT00109577",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "687",
"agreement_id": "671",
"nct_id": "NCT00096356",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "688",
"agreement_id": "672",
"nct_id": "NCT00096382",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "689",
"agreement_id": "673",
"nct_id": "NCT00096447",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "690",
"agreement_id": "674",
"nct_id": "NCT00096460",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "691",
"agreement_id": "675",
"nct_id": "NCT00096681",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "692",
"agreement_id": "676",
"nct_id": "NCT00096785",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "693",
"agreement_id": "677",
"nct_id": "NCT00096941",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "694",
"agreement_id": "678",
"nct_id": "NCT00096954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "695",
"agreement_id": "679",
"nct_id": "NCT00107276",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "696",
"agreement_id": "680",
"nct_id": "NCT00107315",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "697",
"agreement_id": "681",
"nct_id": "NCT00107380",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "698",
"agreement_id": "682",
"nct_id": "NCT00107536",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "699",
"agreement_id": "637",
"nct_id": "NCT00103857",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "700",
"agreement_id": "638",
"nct_id": "NCT00104052",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "701",
"agreement_id": "639",
"nct_id": "NCT00104104",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.'"
},
{
"ID": "702",
"agreement_id": "640",
"nct_id": "NCT00104234",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first publication of the results shall be made by Sponsor in a joint publication. If such a multicenter publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.'"
},
{
"ID": "703",
"agreement_id": "641",
"nct_id": "NCT00104247",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first publication of the results shall be made by Sponsor in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.'"
},
{
"ID": "704",
"agreement_id": "642",
"nct_id": "NCT00094757",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "705",
"agreement_id": "643",
"nct_id": "NCT00094770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "706",
"agreement_id": "644",
"nct_id": "NCT00094809",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "707",
"agreement_id": "645",
"nct_id": "NCT00094835",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "708",
"agreement_id": "646",
"nct_id": "NCT00094861",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "709",
"agreement_id": "647",
"nct_id": "NCT00094887",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "710",
"agreement_id": "613",
"nct_id": "NCT00098813",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "711",
"agreement_id": "614",
"nct_id": "NCT00098839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "712",
"agreement_id": "615",
"nct_id": "NCT00098865",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "713",
"agreement_id": "616",
"nct_id": "NCT00098956",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "714",
"agreement_id": "617",
"nct_id": "NCT00099021",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "715",
"agreement_id": "618",
"nct_id": "NCT00099047",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "716",
"agreement_id": "619",
"nct_id": "NCT00099268",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "717",
"agreement_id": "620",
"nct_id": "NCT00099359",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "718",
"agreement_id": "621",
"nct_id": "NCT00099437",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that they cannot publish any information to do with the trial without written consent from Quintiles.'"
},
{
"ID": "719",
"agreement_id": "622",
"nct_id": "NCT00099632",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights'"
},
{
"ID": "720",
"agreement_id": "623",
"nct_id": "NCT00099983",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "721",
"agreement_id": "624",
"nct_id": "NCT00100048",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "722",
"agreement_id": "732",
"nct_id": "NCT00121225",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "723",
"agreement_id": "733",
"nct_id": "NCT00104299",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "724",
"agreement_id": "734",
"nct_id": "NCT00104416",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "725",
"agreement_id": "735",
"nct_id": "NCT00104520",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications\/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts\/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.'"
},
{
"ID": "726",
"agreement_id": "736",
"nct_id": "NCT00104637",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "727",
"agreement_id": "737",
"nct_id": "NCT00104650",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "728",
"agreement_id": "738",
"nct_id": "NCT00104728",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "729",
"agreement_id": "823",
"nct_id": "NCT00117559",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "730",
"agreement_id": "824",
"nct_id": "NCT00117585",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "731",
"agreement_id": "825",
"nct_id": "NCT00117598",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "732",
"agreement_id": "826",
"nct_id": "NCT00117637",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication will be discussed with the sponsor prior to release and written consent of the sponsor will be obtained. A draft manuscript of the publication or abstract must be sent to sponsor thirty days in advance of submission.'"
},
{
"ID": "733",
"agreement_id": "827",
"nct_id": "NCT00117676",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications\/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts\/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.'"
},
{
"ID": "734",
"agreement_id": "828",
"nct_id": "NCT00117793",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "735",
"agreement_id": "829",
"nct_id": "NCT00117806",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "736",
"agreement_id": "830",
"nct_id": "NCT00117845",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "737",
"agreement_id": "831",
"nct_id": "NCT00117949",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "738",
"agreement_id": "832",
"nct_id": "NCT00117962",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "739",
"agreement_id": "833",
"nct_id": "NCT00117988",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "740",
"agreement_id": "749",
"nct_id": "NCT00105482",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "741",
"agreement_id": "750",
"nct_id": "NCT00105534",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and Principal Investigator shall not publish, present or use any data or results arising out of the performance of this study for their own instruction, research or publication without the prior express written consent of Sponsor.'"
},
{
"ID": "742",
"agreement_id": "751",
"nct_id": "NCT00105989",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "743",
"agreement_id": "752",
"nct_id": "NCT00106002",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "744",
"agreement_id": "753",
"nct_id": "NCT00106028",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The findings of the study may be published in a scientific journal or presented at a scientific meeting. Before submitting the results of the study for publication or presentation, the Investigator will allow the Sponsor 30 days in which to review and comment on the manuscript.'"
},
{
"ID": "745",
"agreement_id": "766",
"nct_id": "NCT00110357",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "746",
"agreement_id": "767",
"nct_id": "NCT00110396",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "SPONSOR shall have the right to publish or present any results or information, including the Study Results, arising in connection with the STUDY for any purposes. The INSTITUTION, its officers, agents, employees and affiliated entities shall not publish or use any results or information arising in connection with the STUDY, including the Study Results, for professional, research, training or other purposes without SPONSOR\u2019s prior written consent.'"
},
{
"ID": "747",
"agreement_id": "768",
"nct_id": "NCT00110461",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PIs may not publish trial results for 18 months - 2 years after trial is completed.'"
},
{
"ID": "748",
"agreement_id": "769",
"nct_id": "NCT00110513",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "749",
"agreement_id": "770",
"nct_id": "NCT00110617",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "750",
"agreement_id": "771",
"nct_id": "NCT00110812",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "751",
"agreement_id": "772",
"nct_id": "NCT00110890",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "752",
"agreement_id": "773",
"nct_id": "NCT00110994",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "753",
"agreement_id": "774",
"nct_id": "NCT00106431",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor can review results at least 60 days prior to the date of submission for publication or public disclosure; sponsor will complete review within review period and will have authority to require institution\/PI to delete confidential information other than the results.'"
},
{
"ID": "754",
"agreement_id": "775",
"nct_id": "NCT00106535",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "755",
"agreement_id": "776",
"nct_id": "NCT00106626",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "756",
"agreement_id": "777",
"nct_id": "NCT00106639",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "757",
"agreement_id": "778",
"nct_id": "NCT00106704",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "758",
"agreement_id": "779",
"nct_id": "NCT00106938",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "759",
"agreement_id": "780",
"nct_id": "NCT00106964",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Adolescent Medicine Trials Network (ATN) for HIV\/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by protocol team and AMLG.'"
},
{
"ID": "760",
"agreement_id": "781",
"nct_id": "NCT00107042",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Adolescent Medicine Trials Network (ATN) for HIV\/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.'"
},
{
"ID": "761",
"agreement_id": "782",
"nct_id": "NCT00107120",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor\u2019s confidential info. Upon sponsor\u2019s request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor\u2019s request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.'"
},
{
"ID": "762",
"agreement_id": "783",
"nct_id": "NCT00113386",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "763",
"agreement_id": "784",
"nct_id": "NCT00113399",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "764",
"agreement_id": "785",
"nct_id": "NCT00113490",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.The PIs also agree for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "765",
"agreement_id": "786",
"nct_id": "NCT00113516",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "766",
"agreement_id": "787",
"nct_id": "NCT00113529",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "767",
"agreement_id": "754",
"nct_id": "NCT00106080",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "768",
"agreement_id": "755",
"nct_id": "NCT00106106",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "769",
"agreement_id": "756",
"nct_id": "NCT00106119",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "770",
"agreement_id": "757",
"nct_id": "NCT00106184",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "771",
"agreement_id": "758",
"nct_id": "NCT00106353",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "772",
"agreement_id": "759",
"nct_id": "NCT00106392",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institute and\/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site\u2019s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.'"
},
{
"ID": "773",
"agreement_id": "760",
"nct_id": "NCT00109967",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "774",
"agreement_id": "761",
"nct_id": "NCT00110019",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "775",
"agreement_id": "762",
"nct_id": "NCT00110084",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "776",
"agreement_id": "763",
"nct_id": "NCT00110136",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "777",
"agreement_id": "764",
"nct_id": "NCT00110214",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "778",
"agreement_id": "765",
"nct_id": "NCT00110305",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "779",
"agreement_id": "708",
"nct_id": "NCT00109590",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights\u201d.'"
},
{
"ID": "780",
"agreement_id": "709",
"nct_id": "NCT00109733",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "781",
"agreement_id": "710",
"nct_id": "NCT00109772",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.'"
},
{
"ID": "782",
"agreement_id": "711",
"nct_id": "NCT00109837",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "783",
"agreement_id": "712",
"nct_id": "NCT00109850",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "784",
"agreement_id": "713",
"nct_id": "NCT00109928",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "785",
"agreement_id": "714",
"nct_id": "NCT00118742",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "786",
"agreement_id": "715",
"nct_id": "NCT00118755",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "787",
"agreement_id": "716",
"nct_id": "NCT00118898",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "788",
"agreement_id": "717",
"nct_id": "NCT00118911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "789",
"agreement_id": "718",
"nct_id": "NCT00119015",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "790",
"agreement_id": "719",
"nct_id": "NCT00119041",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "791",
"agreement_id": "720",
"nct_id": "NCT00119158",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "792",
"agreement_id": "721",
"nct_id": "NCT00119262",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "793",
"agreement_id": "722",
"nct_id": "NCT00119678",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "794",
"agreement_id": "723",
"nct_id": "NCT00120042",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "795",
"agreement_id": "724",
"nct_id": "NCT00120250",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "796",
"agreement_id": "725",
"nct_id": "NCT00120289",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "797",
"agreement_id": "726",
"nct_id": "NCT00120406",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "798",
"agreement_id": "727",
"nct_id": "NCT00120523",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "799",
"agreement_id": "728",
"nct_id": "NCT00120627",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "800",
"agreement_id": "729",
"nct_id": "NCT00121134",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "801",
"agreement_id": "730",
"nct_id": "NCT00121186",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "802",
"agreement_id": "731",
"nct_id": "NCT00121199",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "803",
"agreement_id": "800",
"nct_id": "NCT00114959",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor has the right 60 days before submission for publication to review\/provide comments. If the Sponsor\u2019s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor\u2019s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.'"
},
{
"ID": "804",
"agreement_id": "801",
"nct_id": "NCT00114972",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "805",
"agreement_id": "802",
"nct_id": "NCT00115063",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "806",
"agreement_id": "803",
"nct_id": "NCT00115349",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "807",
"agreement_id": "804",
"nct_id": "NCT00115739",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "808",
"agreement_id": "805",
"nct_id": "NCT00115765",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "809",
"agreement_id": "806",
"nct_id": "NCT00115804",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "810",
"agreement_id": "807",
"nct_id": "NCT00115869",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "811",
"agreement_id": "808",
"nct_id": "NCT00115934",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "812",
"agreement_id": "809",
"nct_id": "NCT00116168",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "813",
"agreement_id": "810",
"nct_id": "NCT00116272",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "814",
"agreement_id": "811",
"nct_id": "NCT00116428",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI is allowed to publish but must submit draft publication(s) to Biosense Webster, Inc. at least 30 days prior to submission for publication or presentation.'"
},
{
"ID": "815",
"agreement_id": "793",
"nct_id": "NCT00113919",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "816",
"agreement_id": "794",
"nct_id": "NCT00114101",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "817",
"agreement_id": "795",
"nct_id": "NCT00114127",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "818",
"agreement_id": "796",
"nct_id": "NCT00114166",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "819",
"agreement_id": "797",
"nct_id": "NCT00114244",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "820",
"agreement_id": "798",
"nct_id": "NCT00114504",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "821",
"agreement_id": "799",
"nct_id": "NCT00114634",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "822",
"agreement_id": "909",
"nct_id": "NCT00127036",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "823",
"agreement_id": "910",
"nct_id": "NCT00127101",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "824",
"agreement_id": "911",
"nct_id": "NCT00127166",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.'"
},
{
"ID": "825",
"agreement_id": "912",
"nct_id": "NCT00127192",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "826",
"agreement_id": "834",
"nct_id": "NCT00121472",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "827",
"agreement_id": "835",
"nct_id": "NCT00121485",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "828",
"agreement_id": "836",
"nct_id": "NCT00121641",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "829",
"agreement_id": "837",
"nct_id": "NCT00121667",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "830",
"agreement_id": "838",
"nct_id": "NCT00121810",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "831",
"agreement_id": "839",
"nct_id": "NCT00121836",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "832",
"agreement_id": "840",
"nct_id": "NCT00122109",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "833",
"agreement_id": "841",
"nct_id": "NCT00122187",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "834",
"agreement_id": "842",
"nct_id": "NCT00122369",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "835",
"agreement_id": "843",
"nct_id": "NCT00122382",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "836",
"agreement_id": "844",
"nct_id": "NCT00122447",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "837",
"agreement_id": "845",
"nct_id": "NCT00122460",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "838",
"agreement_id": "846",
"nct_id": "NCT00111007",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "839",
"agreement_id": "847",
"nct_id": "NCT00111657",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "840",
"agreement_id": "858",
"nct_id": "NCT00112671",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "841",
"agreement_id": "859",
"nct_id": "NCT00112736",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "842",
"agreement_id": "860",
"nct_id": "NCT00112840",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "843",
"agreement_id": "861",
"nct_id": "NCT00112905",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "844",
"agreement_id": "862",
"nct_id": "NCT00112918",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "845",
"agreement_id": "863",
"nct_id": "NCT00113022",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "846",
"agreement_id": "864",
"nct_id": "NCT00113087",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "847",
"agreement_id": "865",
"nct_id": "NCT00113217",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "848",
"agreement_id": "866",
"nct_id": "NCT00113230",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "849",
"agreement_id": "867",
"nct_id": "NCT00113269",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institute and\/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site\u2019s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.'"
},
{
"ID": "850",
"agreement_id": "868",
"nct_id": "NCT00113295",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "851",
"agreement_id": "869",
"nct_id": "NCT00113321",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "852",
"agreement_id": "870",
"nct_id": "NCT00113334",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "853",
"agreement_id": "871",
"nct_id": "NCT00113360",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "854",
"agreement_id": "872",
"nct_id": "NCT00113373",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "855",
"agreement_id": "873",
"nct_id": "NCT00130728",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.'"
},
{
"ID": "856",
"agreement_id": "874",
"nct_id": "NCT00130793",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "857",
"agreement_id": "875",
"nct_id": "NCT00130832",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "858",
"agreement_id": "876",
"nct_id": "NCT00130923",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "859",
"agreement_id": "877",
"nct_id": "NCT00131248",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "860",
"agreement_id": "878",
"nct_id": "NCT00131352",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, principal investigator (PI) can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "861",
"agreement_id": "879",
"nct_id": "NCT00131378",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "862",
"agreement_id": "880",
"nct_id": "NCT00131456",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "863",
"agreement_id": "881",
"nct_id": "NCT00131508",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "864",
"agreement_id": "882",
"nct_id": "NCT00131573",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "865",
"agreement_id": "848",
"nct_id": "NCT00111761",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "866",
"agreement_id": "849",
"nct_id": "NCT00111813",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. Any information identified by the SPONSOR as'"
},
{
"ID": "867",
"agreement_id": "confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "868",
"agreement_id": "850",
"nct_id": "NCT00111917",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "869",
"agreement_id": "851",
"nct_id": "NCT00112047",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI may publish study results 2 years after the completion of the study or earlier with the advance written permission of Gilead. The PI will submit any proposed publication or presentation of study results together with the name of the proposed scientific journal, forum or confeence to Gilead prior to submission or presentation (30 days prior for manuscripts and 15 days for abstracts and oral presentations).'"
},
{
"ID": "870",
"agreement_id": "852",
"nct_id": "NCT00112112",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.The principal investigators (PIs) also agree for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "871",
"agreement_id": "853",
"nct_id": "NCT00112294",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "872",
"agreement_id": "854",
"nct_id": "NCT00112359",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications\/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts\/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.'"
},
{
"ID": "873",
"agreement_id": "855",
"nct_id": "NCT00112385",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "874",
"agreement_id": "856",
"nct_id": "NCT00112437",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "875",
"agreement_id": "857",
"nct_id": "NCT00112489",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "876",
"agreement_id": "812",
"nct_id": "NCT00116649",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "877",
"agreement_id": "813",
"nct_id": "NCT00116688",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "878",
"agreement_id": "814",
"nct_id": "NCT00116753",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "879",
"agreement_id": "815",
"nct_id": "NCT00116779",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of ublication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "880",
"agreement_id": "816",
"nct_id": "NCT00116805",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications\/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts\/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.'"
},
{
"ID": "881",
"agreement_id": "817",
"nct_id": "NCT00116831",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "882",
"agreement_id": "818",
"nct_id": "NCT00116857",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "883",
"agreement_id": "819",
"nct_id": "NCT00117156",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "884",
"agreement_id": "820",
"nct_id": "NCT00117286",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "885",
"agreement_id": "821",
"nct_id": "NCT00117312",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "886",
"agreement_id": "822",
"nct_id": "NCT00117338",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "887",
"agreement_id": "788",
"nct_id": "NCT00113568",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "888",
"agreement_id": "789",
"nct_id": "NCT00113607",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "889",
"agreement_id": "790",
"nct_id": "NCT00113763",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "890",
"agreement_id": "791",
"nct_id": "NCT00113841",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "891",
"agreement_id": "792",
"nct_id": "NCT00113880",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "892",
"agreement_id": "904",
"nct_id": "NCT00126581",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "893",
"agreement_id": "905",
"nct_id": "NCT00126659",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "894",
"agreement_id": "906",
"nct_id": "NCT00126737",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "895",
"agreement_id": "907",
"nct_id": "NCT00126750",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "896",
"agreement_id": "908",
"nct_id": "NCT00126776",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "897",
"agreement_id": "982",
"nct_id": "NCT00132314",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "898",
"agreement_id": "983",
"nct_id": "NCT00132496",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "899",
"agreement_id": "984",
"nct_id": "NCT00132678",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "900",
"agreement_id": "985",
"nct_id": "NCT00132691",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "901",
"agreement_id": "986",
"nct_id": "NCT00132730",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation.'"
},
{
"ID": "902",
"agreement_id": "987",
"nct_id": "NCT00132769",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation.'"
},
{
"ID": "903",
"agreement_id": "988",
"nct_id": "NCT00132808",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "904",
"agreement_id": "913",
"nct_id": "NCT00127413",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "905",
"agreement_id": "914",
"nct_id": "NCT00127530",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.'"
},
{
"ID": "906",
"agreement_id": "915",
"nct_id": "NCT00127712",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "907",
"agreement_id": "916",
"nct_id": "NCT00127790",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "908",
"agreement_id": "917",
"nct_id": "NCT00127803",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications'"
},
{
"ID": "909",
"agreement_id": "918",
"nct_id": "NCT00127842",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "910",
"agreement_id": "919",
"nct_id": "NCT00127855",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "911",
"agreement_id": "920",
"nct_id": "NCT00127933",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "912",
"agreement_id": "921",
"nct_id": "NCT00128180",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "913",
"agreement_id": "922",
"nct_id": "NCT00128193",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "914",
"agreement_id": "923",
"nct_id": "NCT00128206",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "915",
"agreement_id": "924",
"nct_id": "NCT00128219",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "916",
"agreement_id": "925",
"nct_id": "NCT00128401",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "917",
"agreement_id": "926",
"nct_id": "NCT00128492",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications\/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts\/presentations) prior. Any Gilead confidential information in the document(s) must be deleted or, if requested publication, delayed for up to 45 days to permit Gilead to obtain intellectual property protection.'"
},
{
"ID": "918",
"agreement_id": "927",
"nct_id": "NCT00118053",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "919",
"agreement_id": "928",
"nct_id": "NCT00118131",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "920",
"agreement_id": "929",
"nct_id": "NCT00118144",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "921",
"agreement_id": "930",
"nct_id": "NCT00118157",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "922",
"agreement_id": "931",
"nct_id": "NCT00118248",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "923",
"agreement_id": "932",
"nct_id": "NCT00118365",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "924",
"agreement_id": "946",
"nct_id": "NCT00123630",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "925",
"agreement_id": "947",
"nct_id": "NCT00123643",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "926",
"agreement_id": "948",
"nct_id": "NCT00123682",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "927",
"agreement_id": "949",
"nct_id": "NCT00123734",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "928",
"agreement_id": "950",
"nct_id": "NCT00123955",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "929",
"agreement_id": "951",
"nct_id": "NCT00124020",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "930",
"agreement_id": "952",
"nct_id": "NCT00124072",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "931",
"agreement_id": "953",
"nct_id": "NCT00124176",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "932",
"agreement_id": "954",
"nct_id": "NCT00124449",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "933",
"agreement_id": "955",
"nct_id": "NCT00124579",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "934",
"agreement_id": "956",
"nct_id": "NCT00124618",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "935",
"agreement_id": "957",
"nct_id": "NCT00124657",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "936",
"agreement_id": "958",
"nct_id": "NCT00124709",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "937",
"agreement_id": "959",
"nct_id": "NCT00124735",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any scientific paper, presentation, or other communication concerning the clinical trial described in the protocol will first be submitted to Organon, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.'"
},
{
"ID": "938",
"agreement_id": "960",
"nct_id": "NCT00124748",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "939",
"agreement_id": "961",
"nct_id": "NCT00124943",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Study data will not be published in part before the complete multicenter data has been reported in full, unless more than 1 year has elapsed since completion of the Study.'"
},
{
"ID": "940",
"agreement_id": "Investigator\/institution must supply copy of presentation or publication to Celgene within 30 days of publication. Celgene may request in writing within that 30 days that Celgene Confidential Information be deleted or be granted a 60 day delay prior to publication to permit intellectual property filings.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "941",
"agreement_id": "962",
"nct_id": "NCT00124982",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "942",
"agreement_id": "963",
"nct_id": "NCT00125034",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "943",
"agreement_id": "964",
"nct_id": "NCT00125138",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI could publish the results of the Study after the earlier of (a) the cooperative publication of the data, or (b) 18 months after Sponsor\u2019s final evaluation of all data; the PI will submit for review and approval any proposed abstracts and manuscripts at least 45 days prior to submission. The Institution and PI agree to delete any information the Sponsor deems confidential or proprietary; if the parties disagree, then they agree to meet prior to submission to discuss and resolve the issues.'"
},
{
"ID": "944",
"agreement_id": "965",
"nct_id": "NCT00125164",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Each investigator may publish or report data from their own subjects. The trial data in aggregate are the property of Tercica, Inc. and may not be published without permission of Tercica, Inc. Tercica, Inc. will be the final arbitrator of issues relating to the publication or presentation of the aggregate data.'"
},
{
"ID": "945",
"agreement_id": "966",
"nct_id": "NCT00125190",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "946",
"agreement_id": "967",
"nct_id": "NCT00129402",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "947",
"agreement_id": "968",
"nct_id": "NCT00129441",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "948",
"agreement_id": "933",
"nct_id": "NCT00118378",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "949",
"agreement_id": "934",
"nct_id": "NCT00118404",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "950",
"agreement_id": "935",
"nct_id": "NCT00118417",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "951",
"agreement_id": "936",
"nct_id": "NCT00118534",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "952",
"agreement_id": "937",
"nct_id": "NCT00122681",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "953",
"agreement_id": "938",
"nct_id": "NCT00122954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "954",
"agreement_id": "939",
"nct_id": "NCT00122980",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "955",
"agreement_id": "940",
"nct_id": "NCT00123123",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "956",
"agreement_id": "941",
"nct_id": "NCT00123409",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "957",
"agreement_id": "942",
"nct_id": "NCT00123422",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "958",
"agreement_id": "943",
"nct_id": "NCT00123474",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "959",
"agreement_id": "944",
"nct_id": "NCT00123487",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "960",
"agreement_id": "945",
"nct_id": "NCT00123604",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "961",
"agreement_id": "883",
"nct_id": "NCT00131664",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "962",
"agreement_id": "884",
"nct_id": "NCT00131677",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "All presentations and publications of data from CDC funded studies are subject to CDC clearance prior to publication or presentation.'"
},
{
"ID": "963",
"agreement_id": "885",
"nct_id": "NCT00131885",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "964",
"agreement_id": "886",
"nct_id": "NCT00131911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "965",
"agreement_id": "887",
"nct_id": "NCT00131937",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "966",
"agreement_id": "888",
"nct_id": "NCT00132002",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "967",
"agreement_id": "889",
"nct_id": "NCT00132028",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "968",
"agreement_id": "890",
"nct_id": "NCT00132132",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "969",
"agreement_id": "891",
"nct_id": "NCT00125242",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "970",
"agreement_id": "892",
"nct_id": "NCT00125268",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "971",
"agreement_id": "893",
"nct_id": "NCT00125515",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "972",
"agreement_id": "894",
"nct_id": "NCT00125528",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "973",
"agreement_id": "895",
"nct_id": "NCT00125593",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "974",
"agreement_id": "896",
"nct_id": "NCT00125931",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "975",
"agreement_id": "897",
"nct_id": "NCT00125957",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "976",
"agreement_id": "898",
"nct_id": "NCT00126113",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "977",
"agreement_id": "899",
"nct_id": "NCT00126191",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "978",
"agreement_id": "900",
"nct_id": "NCT00126490",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "979",
"agreement_id": "901",
"nct_id": "NCT00126503",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "980",
"agreement_id": "902",
"nct_id": "NCT00126555",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "981",
"agreement_id": "903",
"nct_id": "NCT00126568",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "982",
"agreement_id": "995",
"nct_id": "NCT00134563",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator can publish only the results of the work performed pursuant to this protocol. Prior to publication, the investigator provides the sponsor with the manuscript for review and comment at least 45 days in advance of its submission for publication.'"
},
{
"ID": "983",
"agreement_id": "The sponsor can require the investigator to withhold publication an additional 90 days to allow for filing a patent application or taking such other measures as sponsor deems appropriate to establish and preserve its proprietary rights.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "984",
"agreement_id": "996",
"nct_id": "NCT00134719",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "985",
"agreement_id": "997",
"nct_id": "NCT00134784",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "986",
"agreement_id": "998",
"nct_id": "NCT00134901",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "987",
"agreement_id": "999",
"nct_id": "NCT00135200",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "988",
"agreement_id": "1000",
"nct_id": "NCT00135330",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "989",
"agreement_id": "1001",
"nct_id": "NCT00135356",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "990",
"agreement_id": "1002",
"nct_id": "NCT00135798",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "991",
"agreement_id": "1003",
"nct_id": "NCT00136084",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "992",
"agreement_id": "1004",
"nct_id": "NCT00136318",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "993",
"agreement_id": "1005",
"nct_id": "NCT00136357",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "994",
"agreement_id": "989",
"nct_id": "NCT00132873",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "995",
"agreement_id": "990",
"nct_id": "NCT00133575",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "996",
"agreement_id": "991",
"nct_id": "NCT00133705",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "997",
"agreement_id": "992",
"nct_id": "NCT00133978",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "998",
"agreement_id": "993",
"nct_id": "NCT00134004",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "999",
"agreement_id": "994",
"nct_id": "NCT00134043",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1000",
"agreement_id": "1007",
"nct_id": "NCT00136916",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1001",
"agreement_id": "1008",
"nct_id": "NCT00136955",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1002",
"agreement_id": "1009",
"nct_id": "NCT00137046",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1003",
"agreement_id": "1010",
"nct_id": "NCT00137111",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1004",
"agreement_id": "1011",
"nct_id": "NCT00137267",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1005",
"agreement_id": "1012",
"nct_id": "NCT00137280",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1006",
"agreement_id": "1013",
"nct_id": "NCT00137423",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1007",
"agreement_id": "1014",
"nct_id": "NCT00137436",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1008",
"agreement_id": "1015",
"nct_id": "NCT00137449",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosure, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1009",
"agreement_id": "1016",
"nct_id": "NCT00137631",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1010",
"agreement_id": "1017",
"nct_id": "NCT00137969",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1011",
"agreement_id": "1018",
"nct_id": "NCT00138034",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Freek W.A. Verheugt'"
},
{
"ID": "1012",
"agreement_id": "has to following potential conflict of interest:'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1013",
"agreement_id": "received educational and research grants from Bayer Healthcare, Roche, Eli Lilly and Boehringer Ingelheim'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1014",
"agreement_id": "received honoraria for consultancies from Daiichi-Sankyo, Eli Lilly, Merck, The Medicines Company and Bayer Healthcare'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1015",
"agreement_id": "1019",
"nct_id": "NCT00138073",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1016",
"agreement_id": "1020",
"nct_id": "NCT00138125",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1017",
"agreement_id": "1021",
"nct_id": "NCT00138151",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1018",
"agreement_id": "1022",
"nct_id": "NCT00138203",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1019",
"agreement_id": "1023",
"nct_id": "NCT00138424",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1020",
"agreement_id": "1024",
"nct_id": "NCT00138645",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1021",
"agreement_id": "1025",
"nct_id": "NCT00138658",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review proposed written or oral material which describes the results of the Study prior to public release and can embargo communications for a period that is less than or equal to 60 days from the time submitted to the sponsor for review.'"
},
{
"ID": "1022",
"agreement_id": "The results from one institution shall not be presented before the multi-center publication. If there is no multi-center publication within 12 months after the Study completion the Investigator shall have the right to publish the results.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1023",
"agreement_id": "1026",
"nct_id": "NCT00138671",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1024",
"agreement_id": "1027",
"nct_id": "NCT00139477",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1025",
"agreement_id": "1028",
"nct_id": "NCT00139659",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1026",
"agreement_id": "1041",
"nct_id": "NCT00129311",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1027",
"agreement_id": "1042",
"nct_id": "NCT00145119",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1028",
"agreement_id": "1043",
"nct_id": "NCT00145249",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1029",
"agreement_id": "1044",
"nct_id": "NCT00145327",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1030",
"agreement_id": "1045",
"nct_id": "NCT00145418",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1031",
"agreement_id": "1046",
"nct_id": "NCT00145496",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Except for compelling legal reasons, neither the sponsor nor the investigator will communicate to third parties any result of the clinical trial before the clinical trial report has been released by the sponsor.'"
},
{
"ID": "1032",
"agreement_id": "1047",
"nct_id": "NCT00145509",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution will provide manuscripts, abstracts, or the full text of any other intended disclosure to the sponsor at least 30 days prior to submission for publication or other disclosure. If any patent action is required to protect intellectual property rights, Institution agrees to delay the disclosure for a period not to exceed and additional 60 days. Institution will, on request, remove any previously undisclosed Confidential Information (other than study results) before disclosure.'"
},
{
"ID": "1033",
"agreement_id": "1048",
"nct_id": "NCT00145574",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor reflects the following restrictive language in the Clinical Study Agreements: \u0022If identified by Daiichi Sankyo,Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted\u2026Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site.\u0022'"
},
{
"ID": "1034",
"agreement_id": "1049",
"nct_id": "NCT00145587",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1035",
"agreement_id": "1050",
"nct_id": "NCT00145600",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1036",
"agreement_id": "1051",
"nct_id": "NCT00145704",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1037",
"agreement_id": "1052",
"nct_id": "NCT00145795",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1038",
"agreement_id": "1053",
"nct_id": "NCT00146328",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1039",
"agreement_id": "1054",
"nct_id": "NCT00146757",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "1040",
"agreement_id": "1055",
"nct_id": "NCT00146770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "1041",
"agreement_id": "1056",
"nct_id": "NCT00146848",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review.'"
},
{
"ID": "1042",
"agreement_id": "1057",
"nct_id": "NCT00147199",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results are described in the investigator contract.'"
},
{
"ID": "1043",
"agreement_id": "1058",
"nct_id": "NCT00147212",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1044",
"agreement_id": "1059",
"nct_id": "NCT00147225",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1045",
"agreement_id": "1060",
"nct_id": "NCT00147238",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1046",
"agreement_id": "1061",
"nct_id": "NCT00147277",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1047",
"agreement_id": "1062",
"nct_id": "NCT00147290",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1048",
"agreement_id": "1063",
"nct_id": "NCT00147316",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1049",
"agreement_id": "1064",
"nct_id": "NCT00147446",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1050",
"agreement_id": "1065",
"nct_id": "NCT00147498",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1051",
"agreement_id": "1066",
"nct_id": "NCT00147537",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1052",
"agreement_id": "1029",
"nct_id": "NCT00139737",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1053",
"agreement_id": "1030",
"nct_id": "NCT00139776",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1054",
"agreement_id": "1031",
"nct_id": "NCT00139997",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1055",
"agreement_id": "1032",
"nct_id": "NCT00128661",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1056",
"agreement_id": "1033",
"nct_id": "NCT00128713",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1057",
"agreement_id": "1034",
"nct_id": "NCT00128830",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1058",
"agreement_id": "1035",
"nct_id": "NCT00128921",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1059",
"agreement_id": "1036",
"nct_id": "NCT00129116",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1060",
"agreement_id": "1037",
"nct_id": "NCT00129129",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1061",
"agreement_id": "1038",
"nct_id": "NCT00129220",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1062",
"agreement_id": "1039",
"nct_id": "NCT00129246",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1063",
"agreement_id": "1040",
"nct_id": "NCT00129259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1064",
"agreement_id": "1069",
"nct_id": "NCT00147966",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1065",
"agreement_id": "1070",
"nct_id": "NCT00148109",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1066",
"agreement_id": "1071",
"nct_id": "NCT00148122",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1067",
"agreement_id": "1072",
"nct_id": "NCT00148668",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1068",
"agreement_id": "1073",
"nct_id": "NCT00148733",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1069",
"agreement_id": "1074",
"nct_id": "NCT00151476",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1070",
"agreement_id": "1075",
"nct_id": "NCT00151775",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If identified by Daiichi Sankyo Inc.(DSI), any of DSI's confidential information, as defined to the author, shall be deleted. Nothing in our site agreement shall be taken as giving DSI any right of editorial control over any publication prepared by the study site.'"
},
{
"ID": "1071",
"agreement_id": "1076",
"nct_id": "NCT00151814",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1072",
"agreement_id": "1077",
"nct_id": "NCT00151892",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1073",
"agreement_id": "1078",
"nct_id": "NCT00151996",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1074",
"agreement_id": "1079",
"nct_id": "NCT00152009",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1075",
"agreement_id": "1006",
"nct_id": "NCT00136760",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1076",
"agreement_id": "969",
"nct_id": "NCT00129467",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1077",
"agreement_id": "970",
"nct_id": "NCT00129480",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1078",
"agreement_id": "971",
"nct_id": "NCT00129545",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1079",
"agreement_id": "972",
"nct_id": "NCT00129753",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1080",
"agreement_id": "973",
"nct_id": "NCT00129766",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1081",
"agreement_id": "974",
"nct_id": "NCT00129961",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1082",
"agreement_id": "975",
"nct_id": "NCT00130039",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1083",
"agreement_id": "976",
"nct_id": "NCT00130247",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1084",
"agreement_id": "977",
"nct_id": "NCT00130286",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1085",
"agreement_id": "978",
"nct_id": "NCT00130520",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1086",
"agreement_id": "979",
"nct_id": "NCT00130637",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1087",
"agreement_id": "980",
"nct_id": "NCT00130689",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1088",
"agreement_id": "981",
"nct_id": "NCT00148759",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1089",
"agreement_id": "1093",
"nct_id": "NCT00154375",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1090",
"agreement_id": "1094",
"nct_id": "NCT00154466",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1091",
"agreement_id": "1095",
"nct_id": "NCT00156013",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1092",
"agreement_id": "1096",
"nct_id": "NCT00156065",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Except for compelling legal reasons, neither the sponsor nor the investigator will communicate to third parties any result of the clinical trial before the CTR has been released by the sponsor.'"
},
{
"ID": "1093",
"agreement_id": "1097",
"nct_id": "NCT00156247",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1094",
"agreement_id": "1098",
"nct_id": "NCT00156390",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1095",
"agreement_id": "1099",
"nct_id": "NCT00156533",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1096",
"agreement_id": "1100",
"nct_id": "NCT00156715",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1097",
"agreement_id": "1101",
"nct_id": "NCT00156910",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1098",
"agreement_id": "1102",
"nct_id": "NCT00156923",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Should a PI wish to disclose results, the sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days but less than or equal to 90 days from the time submitted to the sponsor for review. Revisions will be negotiated in good faith. For a multicenter study the institution\/PI agree to publish\/publicly present the results together with the other sites unless the sponsor grants written permission in advance.'"
},
{
"ID": "1099",
"agreement_id": "1103",
"nct_id": "NCT00161213",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1100",
"agreement_id": "1104",
"nct_id": "NCT00161382",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1101",
"agreement_id": "1105",
"nct_id": "NCT00161473",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1102",
"agreement_id": "1106",
"nct_id": "NCT00161616",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1103",
"agreement_id": "1107",
"nct_id": "NCT00162032",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1104",
"agreement_id": "1108",
"nct_id": "NCT00162097",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1105",
"agreement_id": "1109",
"nct_id": "NCT00162123",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1106",
"agreement_id": "1110",
"nct_id": "NCT00162136",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1107",
"agreement_id": "1111",
"nct_id": "NCT00162266",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1108",
"agreement_id": "1112",
"nct_id": "NCT00162942",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1109",
"agreement_id": "1113",
"nct_id": "NCT00162981",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Principal Investigator agrees to delete, at Sponsor\u2019s request, from any proposed Public Presentation any information or material that Sponsor deems confidential or proprietary.'"
},
{
"ID": "1110",
"agreement_id": "1114",
"nct_id": "NCT00163020",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1111",
"agreement_id": "1115",
"nct_id": "NCT00163189",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1112",
"agreement_id": "1129",
"nct_id": "NCT00140413",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "With respect to any proposed publication, the PI must submit to the sponsor a copy of the proposed publication at least 2 months prior to submission for the purposes of: providing the sponsor the oppotunity to review and comment on the contents of proposed publication; and to identify any trade secret, proprietary or confidential information to be removed from the proposed publication. The sponsor will provide comments within 30 days of receipt of proposed publication.'"
},
{
"ID": "1113",
"agreement_id": "1130",
"nct_id": "NCT00140556",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1114",
"agreement_id": "1131",
"nct_id": "NCT00140621",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Prior to publishing results from this study in academic meetings, medical journals, etc., the investigator and subinvestigator of the post-manufacturing\/marketing clinical study must obtain the approval from the sponsor of the post-manufacturing\/marketing clinical study in writing.'"
},
{
"ID": "1115",
"agreement_id": "1132",
"nct_id": "NCT00140842",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1116",
"agreement_id": "1133",
"nct_id": "NCT00141037",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1117",
"agreement_id": "1134",
"nct_id": "NCT00141102",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1118",
"agreement_id": "1135",
"nct_id": "NCT00141219",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1119",
"agreement_id": "1136",
"nct_id": "NCT00141271",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1120",
"agreement_id": "1137",
"nct_id": "NCT00141453",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Results of Study shall not be published without prior express written consent and approval of Sponsor. Sponsor has right to change proposed publication and\/or prohibit publication and Contractor must comply with requirements of Sponsor.'"
},
{
"ID": "1121",
"agreement_id": "1138",
"nct_id": "NCT00141726",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1122",
"agreement_id": "1139",
"nct_id": "NCT00141739",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1123",
"agreement_id": "1140",
"nct_id": "NCT00141765",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1124",
"agreement_id": "1141",
"nct_id": "NCT00141778",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1125",
"agreement_id": "1142",
"nct_id": "NCT00141817",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1126",
"agreement_id": "1143",
"nct_id": "NCT00142116",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1127",
"agreement_id": "1144",
"nct_id": "NCT00142298",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.'"
},
{
"ID": "1128",
"agreement_id": "1145",
"nct_id": "NCT00142597",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1129",
"agreement_id": "1146",
"nct_id": "NCT00142818",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1130",
"agreement_id": "1147",
"nct_id": "NCT00142909",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1131",
"agreement_id": "1148",
"nct_id": "NCT00142935",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1132",
"agreement_id": "1149",
"nct_id": "NCT00143247",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1133",
"agreement_id": "1150",
"nct_id": "NCT00143312",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1134",
"agreement_id": "1151",
"nct_id": "NCT00143390",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1135",
"agreement_id": "1152",
"nct_id": "NCT00143403",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1136",
"agreement_id": "1116",
"nct_id": "NCT00163215",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1137",
"agreement_id": "1117",
"nct_id": "NCT00163293",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1138",
"agreement_id": "1118",
"nct_id": "NCT00165646",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1139",
"agreement_id": "1119",
"nct_id": "NCT00165672",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1140",
"agreement_id": "1120",
"nct_id": "NCT00165698",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1141",
"agreement_id": "1121",
"nct_id": "NCT00165776",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1142",
"agreement_id": "1122",
"nct_id": "NCT00165789",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1143",
"agreement_id": "1123",
"nct_id": "NCT00165841",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1144",
"agreement_id": "1124",
"nct_id": "NCT00165958",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1145",
"agreement_id": "1125",
"nct_id": "NCT00165984",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1146",
"agreement_id": "1126",
"nct_id": "NCT00166036",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1147",
"agreement_id": "1127",
"nct_id": "NCT00166114",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1148",
"agreement_id": "1128",
"nct_id": "NCT00140140",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Celgene shall complete its review within 30 days after receipt of a proposed publication or presentation submitted by the investigator. Upon request, the publication\/presentation might be delayed up to 60 additional days for Celgene to secure intellectual property protection. Subsequent to the multicenter publication or one year after study completion, whichever occurs first, an investigator and\/or his\/her colleagues may publish the results of INVESTIGATOR's part of the study independently.'"
},
{
"ID": "1149",
"agreement_id": "1067",
"nct_id": "NCT00147745",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If identified by Daiichi Sankyo, Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted\u2026Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by Study Site.'"
},
{
"ID": "1150",
"agreement_id": "1068",
"nct_id": "NCT00147823",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1151",
"agreement_id": "1245",
"nct_id": "NCT00157248",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract'"
},
{
"ID": "1152",
"agreement_id": "1246",
"nct_id": "NCT00157755",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1153",
"agreement_id": "1247",
"nct_id": "NCT00157820",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1154",
"agreement_id": "1248",
"nct_id": "NCT00157950",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1155",
"agreement_id": "1249",
"nct_id": "NCT00158197",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1156",
"agreement_id": "1250",
"nct_id": "NCT00158223",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1157",
"agreement_id": "1217",
"nct_id": "NCT00168038",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.'"
},
{
"ID": "1158",
"agreement_id": "1218",
"nct_id": "NCT00168064",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1159",
"agreement_id": "1219",
"nct_id": "NCT00168103",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.'"
},
{
"ID": "1160",
"agreement_id": "1220",
"nct_id": "NCT00168298",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1161",
"agreement_id": "1080",
"nct_id": "NCT00152516",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1162",
"agreement_id": "1081",
"nct_id": "NCT00152763",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1163",
"agreement_id": "1082",
"nct_id": "NCT00152971",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract'"
},
{
"ID": "1164",
"agreement_id": "1083",
"nct_id": "NCT00153062",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1165",
"agreement_id": "1084",
"nct_id": "NCT00153101",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1166",
"agreement_id": "1085",
"nct_id": "NCT00153166",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1167",
"agreement_id": "1086",
"nct_id": "NCT00153179",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1168",
"agreement_id": "1087",
"nct_id": "NCT00153985",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1169",
"agreement_id": "1088",
"nct_id": "NCT00154063",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1170",
"agreement_id": "1089",
"nct_id": "NCT00154102",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1171",
"agreement_id": "1090",
"nct_id": "NCT00154284",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1172",
"agreement_id": "1091",
"nct_id": "NCT00154297",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1173",
"agreement_id": "1092",
"nct_id": "NCT00154310",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1174",
"agreement_id": "1166",
"nct_id": "NCT00149214",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1175",
"agreement_id": "1167",
"nct_id": "NCT00149227",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1176",
"agreement_id": "1168",
"nct_id": "NCT00149630",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1177",
"agreement_id": "1169",
"nct_id": "NCT00149643",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1178",
"agreement_id": "1170",
"nct_id": "NCT00149747",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1179",
"agreement_id": "1171",
"nct_id": "NCT00149799",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1180",
"agreement_id": "1172",
"nct_id": "NCT00149825",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1181",
"agreement_id": "1173",
"nct_id": "NCT00149890",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1182",
"agreement_id": "1174",
"nct_id": "NCT00149994",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1183",
"agreement_id": "1175",
"nct_id": "NCT00150176",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor will be provided an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.'"
},
{
"ID": "1184",
"agreement_id": "Materials for intended disclosure must be provided to sponsor at least 30 days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, then the disclosure must be delayed for a period not to exceed an additional 60 days.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1185",
"agreement_id": "1176",
"nct_id": "NCT00150345",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1186",
"agreement_id": "1177",
"nct_id": "NCT00150592",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1187",
"agreement_id": "1192",
"nct_id": "NCT00183625",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1188",
"agreement_id": "1193",
"nct_id": "NCT00183794",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1189",
"agreement_id": "1194",
"nct_id": "NCT00183963",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1190",
"agreement_id": "1195",
"nct_id": "NCT00184028",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1191",
"agreement_id": "1196",
"nct_id": "NCT00184054",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1192",
"agreement_id": "1197",
"nct_id": "NCT00184548",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Novo Nordisk acknowledges the Investigator\u2019s right to publish the entire results of the trial in accordance with the latest Vancouver guidelines. Any such scientific paper, resentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication \/ presentation for comments. Comments will be given within four weeks from receipt of the manuscript.'"
},
{
"ID": "1193",
"agreement_id": "1198",
"nct_id": "NCT00184600",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Novo Nordisk reserves the right to not release data until specified milestones are reached. This includes the right to not release interim results of clinical trials, because that can invalidate results of the entire trial. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and\/or communication for less than 60 days to protect intellectual property.'"
},
{
"ID": "1194",
"agreement_id": "1199",
"nct_id": "NCT00184717",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Novo Nordisk acknowledges the Investigator\u2019s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication\/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.'"
},
{
"ID": "1195",
"agreement_id": "1200",
"nct_id": "NCT00185211",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Submit for review any manuscript \/ abstract related to the Study at least 90 days prior to publication.The proposed publication \/ presentation shall only be made after BSP has obtained adequate patent protection for the Results, or after the patentable information has been taken out of the publication\/presentation.'"
},
{
"ID": "1196",
"agreement_id": "1201",
"nct_id": "NCT00185380",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor is interested in the publication of the results of every study. As some of the information concerning the study drug and the sponsor's development activities may be strictly confidential, any publication manuscript (including conference contributions, etc.) must first be reviewed by the sponsor before its submission or presentation.'"
},
{
"ID": "1197",
"agreement_id": "1202",
"nct_id": "NCT00185458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigators agree to allow the sponsor to review any manuscripts and to negotiate the times and forums of their publication.'"
},
{
"ID": "1198",
"agreement_id": "1203",
"nct_id": "NCT00185588",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1199",
"agreement_id": "1204",
"nct_id": "NCT00185679",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1200",
"agreement_id": "1205",
"nct_id": "NCT00185965",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1201",
"agreement_id": "1206",
"nct_id": "NCT00186875",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1202",
"agreement_id": "1207",
"nct_id": "NCT00186888",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1203",
"agreement_id": "1208",
"nct_id": "NCT00186901",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1204",
"agreement_id": "1209",
"nct_id": "NCT00187096",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1205",
"agreement_id": "1210",
"nct_id": "NCT00166517",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1206",
"agreement_id": "1211",
"nct_id": "NCT00166712",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1207",
"agreement_id": "1212",
"nct_id": "NCT00167102",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1208",
"agreement_id": "1213",
"nct_id": "NCT00167206",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1209",
"agreement_id": "1214",
"nct_id": "NCT00167245",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1210",
"agreement_id": "1215",
"nct_id": "NCT00167544",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1211",
"agreement_id": "1216",
"nct_id": "NCT00167778",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1212",
"agreement_id": "1228",
"nct_id": "NCT00168818",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract'"
},
{
"ID": "1213",
"agreement_id": "1229",
"nct_id": "NCT00168831",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1214",
"agreement_id": "1230",
"nct_id": "NCT00168844",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1215",
"agreement_id": "1231",
"nct_id": "NCT00170157",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1216",
"agreement_id": "1232",
"nct_id": "NCT00170846",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1217",
"agreement_id": "1233",
"nct_id": "NCT00170950",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1218",
"agreement_id": "1234",
"nct_id": "NCT00171054",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1219",
"agreement_id": "1235",
"nct_id": "NCT00171210",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1220",
"agreement_id": "1236",
"nct_id": "NCT00166166",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1221",
"agreement_id": "1237",
"nct_id": "NCT00166205",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI shall have the right to publish the results of research to include in any publication. The PI will provide the Sponsor with at least sixty (60) days for review of a manuscript. No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.'"
},
{
"ID": "1222",
"agreement_id": "1238",
"nct_id": "NCT00166296",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1223",
"agreement_id": "1239",
"nct_id": "NCT00166361",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1224",
"agreement_id": "1240",
"nct_id": "NCT00166504",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1225",
"agreement_id": "1241",
"nct_id": "NCT00156936",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Should a PI wish to disclose results, the sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days but less than or equal to 90 days from the time submitted to the sponsor for review. Revisions will be negotiated in good faith. For a multicenter study, the institution\/PI agree to publish\/publicly present the results together with the other sites unless the sponsor grants written permission in advance.'"
},
{
"ID": "1226",
"agreement_id": "1242",
"nct_id": "NCT00157014",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institute and\/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site\u2019s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.'"
},
{
"ID": "1227",
"agreement_id": "1243",
"nct_id": "NCT00157157",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Baxter's agreements with PIs vary per individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) 30 days prior to submission or communication. Baxter may request an additional delay of up to 90 days (e.g., to allow for intellectual property protection).'"
},
{
"ID": "1228",
"agreement_id": "1244",
"nct_id": "NCT00157196",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.'"
},
{
"ID": "1229",
"agreement_id": "1329",
"nct_id": "NCT00171704",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in clinical trial.'"
},
{
"ID": "1230",
"agreement_id": "1330",
"nct_id": "NCT00171834",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1231",
"agreement_id": "1331",
"nct_id": "NCT00171873",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1232",
"agreement_id": "1332",
"nct_id": "NCT00171925",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1233",
"agreement_id": "1300",
"nct_id": "NCT00189488",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1234",
"agreement_id": "1301",
"nct_id": "NCT00189540",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Multi-center all inclusive initial publication planned. Any proposed publications must be submitted to the steering committee and sponsor thirty (30) days prior to publication submission.'"
},
{
"ID": "1235",
"agreement_id": "1302",
"nct_id": "NCT00190671",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1236",
"agreement_id": "1303",
"nct_id": "NCT00190684",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1237",
"agreement_id": "1304",
"nct_id": "NCT00190749",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1238",
"agreement_id": "1305",
"nct_id": "NCT00190775",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1239",
"agreement_id": "1221",
"nct_id": "NCT00168311",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1240",
"agreement_id": "1222",
"nct_id": "NCT00168324",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1241",
"agreement_id": "1223",
"nct_id": "NCT00168337",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1242",
"agreement_id": "1224",
"nct_id": "NCT00168389",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1243",
"agreement_id": "1225",
"nct_id": "NCT00168428",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1244",
"agreement_id": "1226",
"nct_id": "NCT00168454",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1245",
"agreement_id": "1227",
"nct_id": "NCT00168805",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract'"
},
{
"ID": "1246",
"agreement_id": "1178",
"nct_id": "NCT00150618",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1247",
"agreement_id": "1179",
"nct_id": "NCT00150969",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1248",
"agreement_id": "1180",
"nct_id": "NCT00151372",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1249",
"agreement_id": "1181",
"nct_id": "NCT00151411",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1250",
"agreement_id": "1182",
"nct_id": "NCT00182078",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1251",
"agreement_id": "1183",
"nct_id": "NCT00182091",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1252",
"agreement_id": "1184",
"nct_id": "NCT00182689",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1253",
"agreement_id": "1185",
"nct_id": "NCT00183092",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1254",
"agreement_id": "1186",
"nct_id": "NCT00183196",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1255",
"agreement_id": "1187",
"nct_id": "NCT00183248",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1256",
"agreement_id": "1188",
"nct_id": "NCT00183339",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1257",
"agreement_id": "1189",
"nct_id": "NCT00183430",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1258",
"agreement_id": "1190",
"nct_id": "NCT00183456",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1259",
"agreement_id": "1191",
"nct_id": "NCT00183469",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1260",
"agreement_id": "1153",
"nct_id": "NCT00143455",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1261",
"agreement_id": "1154",
"nct_id": "NCT00143507",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review publication and\/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.'"
},
{
"ID": "1262",
"agreement_id": "1155",
"nct_id": "NCT00143598",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1263",
"agreement_id": "1156",
"nct_id": "NCT00143845",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1264",
"agreement_id": "1157",
"nct_id": "NCT00144027",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1265",
"agreement_id": "1158",
"nct_id": "NCT00144170",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1266",
"agreement_id": "1159",
"nct_id": "NCT00144300",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1267",
"agreement_id": "1160",
"nct_id": "NCT00144339",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1268",
"agreement_id": "1161",
"nct_id": "NCT00144781",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "1269",
"agreement_id": "1162",
"nct_id": "NCT00144963",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1270",
"agreement_id": "1163",
"nct_id": "NCT00145041",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1271",
"agreement_id": "1164",
"nct_id": "NCT00148798",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1272",
"agreement_id": "1165",
"nct_id": "NCT00148954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1273",
"agreement_id": "1274",
"nct_id": "NCT00179621",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 1 year after study completion.'"
},
{
"ID": "1274",
"agreement_id": "Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 90 days.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1275",
"agreement_id": "1275",
"nct_id": "NCT00179647",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present the clinical data generated from the study provided that such Investigator shall furnish sponsor with a copy of the proposed publication or presentation at least 60 days in advance of submission, delete any confidential information, and delay submission for up to 90 days to permit the preparation and filing of appropriate intellectual property applications.'"
},
{
"ID": "1276",
"agreement_id": "1276",
"nct_id": "NCT00179660",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.'"
},
{
"ID": "1277",
"agreement_id": "1277",
"nct_id": "NCT00179673",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to publish and\/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.'"
},
{
"ID": "1278",
"agreement_id": "1278",
"nct_id": "NCT00179959",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1279",
"agreement_id": "1279",
"nct_id": "NCT00180271",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1280",
"agreement_id": "1280",
"nct_id": "NCT00180323",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1281",
"agreement_id": "1281",
"nct_id": "NCT00180479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1282",
"agreement_id": "1282",
"nct_id": "NCT00180687",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1283",
"agreement_id": "1283",
"nct_id": "NCT00181610",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1284",
"agreement_id": "1284",
"nct_id": "NCT00187135",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1285",
"agreement_id": "1285",
"nct_id": "NCT00187200",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publications and presentation should be presented to sponsor 30 days (manuscripts) or 7 days (abstracts) prior to submission for publication. The sponsor reserves the right to deny submission of study results if based on data owned by sponsor.'"
},
{
"ID": "1286",
"agreement_id": "1286",
"nct_id": "NCT00187226",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1287",
"agreement_id": "1287",
"nct_id": "NCT00187486",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1288",
"agreement_id": "1288",
"nct_id": "NCT00187655",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1289",
"agreement_id": "1289",
"nct_id": "NCT00187681",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1290",
"agreement_id": "1290",
"nct_id": "NCT00187720",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1291",
"agreement_id": "1291",
"nct_id": "NCT00187876",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1292",
"agreement_id": "1292",
"nct_id": "NCT00187889",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1293",
"agreement_id": "1293",
"nct_id": "NCT00189098",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1294",
"agreement_id": "1294",
"nct_id": "NCT00189137",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1295",
"agreement_id": "1295",
"nct_id": "NCT00189306",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1296",
"agreement_id": "1296",
"nct_id": "NCT00189423",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1297",
"agreement_id": "1297",
"nct_id": "NCT00189436",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1298",
"agreement_id": "1298",
"nct_id": "NCT00189462",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1299",
"agreement_id": "1299",
"nct_id": "NCT00189475",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1300",
"agreement_id": "1311",
"nct_id": "NCT00191165",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1301",
"agreement_id": "1312",
"nct_id": "NCT00191191",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1302",
"agreement_id": "1313",
"nct_id": "NCT00191269",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1303",
"agreement_id": "1314",
"nct_id": "NCT00191282",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1304",
"agreement_id": "1315",
"nct_id": "NCT00191308",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1305",
"agreement_id": "1316",
"nct_id": "NCT00191334",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1306",
"agreement_id": "1317",
"nct_id": "NCT00191386",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1307",
"agreement_id": "1318",
"nct_id": "NCT00191451",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1308",
"agreement_id": "1319",
"nct_id": "NCT00191477",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1309",
"agreement_id": "1320",
"nct_id": "NCT00191646",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1310",
"agreement_id": "1321",
"nct_id": "NCT00191724",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1311",
"agreement_id": "1322",
"nct_id": "NCT00191789",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1312",
"agreement_id": "1323",
"nct_id": "NCT00191815",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1313",
"agreement_id": "1324",
"nct_id": "NCT00191854",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1314",
"agreement_id": "1325",
"nct_id": "NCT00191906",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1315",
"agreement_id": "1326",
"nct_id": "NCT00171301",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1316",
"agreement_id": "1327",
"nct_id": "NCT00171314",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1317",
"agreement_id": "1328",
"nct_id": "NCT00171340",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1318",
"agreement_id": "1803",
"nct_id": "NCT00308113",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1319",
"agreement_id": "1804",
"nct_id": "NCT00308139",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1320",
"agreement_id": "1805",
"nct_id": "NCT00308230",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1321",
"agreement_id": "1806",
"nct_id": "NCT00325897",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1322",
"agreement_id": "1807",
"nct_id": "NCT00326001",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1323",
"agreement_id": "1808",
"nct_id": "NCT00326118",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1324",
"agreement_id": "1809",
"nct_id": "NCT00326170",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1325",
"agreement_id": "1810",
"nct_id": "NCT00326183",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1326",
"agreement_id": "1811",
"nct_id": "NCT00326196",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1327",
"agreement_id": "1812",
"nct_id": "NCT00330460",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1328",
"agreement_id": "1813",
"nct_id": "NCT00330564",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1329",
"agreement_id": "2001",
"nct_id": "NCT00237796",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1330",
"agreement_id": "2002",
"nct_id": "NCT00238108",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1331",
"agreement_id": "2003",
"nct_id": "NCT00238121",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1332",
"agreement_id": "2004",
"nct_id": "NCT00238303",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1333",
"agreement_id": "2113",
"nct_id": "NCT00243022",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1334",
"agreement_id": "2114",
"nct_id": "NCT00243061",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1335",
"agreement_id": "2115",
"nct_id": "NCT00243191",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1336",
"agreement_id": "2116",
"nct_id": "NCT00328263",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any proposed publication or formal presentation of the data directly derived from the study shall be submitted to Bio-K+. Bio-K+ will have 15 business days to give comments to the Investigator.This review is no way intended to restrict publication of facts or opinions formulated by the Investigator through this research.'"
},
{
"ID": "1337",
"agreement_id": "2117",
"nct_id": "NCT00328510",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1338",
"agreement_id": "2118",
"nct_id": "NCT00328562",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1339",
"agreement_id": "2119",
"nct_id": "NCT00328614",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1340",
"agreement_id": "2120",
"nct_id": "NCT00264004",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "1341",
"agreement_id": "2317",
"nct_id": "NCT00283816",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1342",
"agreement_id": "2318",
"nct_id": "NCT00283842",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication'"
},
{
"ID": "1343",
"agreement_id": "2365",
"nct_id": "NCT00227266",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1344",
"agreement_id": "2366",
"nct_id": "NCT00305942",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "1345",
"agreement_id": "2367",
"nct_id": "NCT00306163",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1346",
"agreement_id": "2368",
"nct_id": "NCT00306189",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1347",
"agreement_id": "2369",
"nct_id": "NCT00306202",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1348",
"agreement_id": "2370",
"nct_id": "NCT00306384",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1349",
"agreement_id": "2371",
"nct_id": "NCT00306488",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1350",
"agreement_id": "2372",
"nct_id": "NCT00306527",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1351",
"agreement_id": "1549",
"nct_id": "NCT00203268",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1352",
"agreement_id": "1550",
"nct_id": "NCT00203294",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1353",
"agreement_id": "1551",
"nct_id": "NCT00203307",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1354",
"agreement_id": "1552",
"nct_id": "NCT00203424",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The obligations of confidentiality shall apply for a period of 5 years beyond termination of Agreement between Sponsor and PI,but do not apply to the extent information:is or later becomes generally known to the public;is obtained from third party without restriction who had legal right to disclose;is already possessed by PI,as demonstrated by recipient\u2019s written records predating receipt from Sponsor;or is required to be disclosed pursuant to a subpoena,law,regulation,or other legal proceeding.'"
},
{
"ID": "1355",
"agreement_id": "1553",
"nct_id": "NCT00203476",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1356",
"agreement_id": "1554",
"nct_id": "NCT00203892",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1357",
"agreement_id": "1555",
"nct_id": "NCT00203931",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1358",
"agreement_id": "1556",
"nct_id": "NCT00203996",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1359",
"agreement_id": "1604",
"nct_id": "NCT00325195",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Multicenter publication is to be generated before any individual PI publishes on the results. If multicenter publication is not completed within 18 months from the date of completion, then PI can publish individual results from the Study. Sponsor can review results prior to public release and embargo for no more than 90 days. Sponsor can request removal of Confidential Information only.'"
},
{
"ID": "1360",
"agreement_id": "1605",
"nct_id": "NCT00325234",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1361",
"agreement_id": "1606",
"nct_id": "NCT00325403",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1362",
"agreement_id": "1814",
"nct_id": "NCT00330616",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1363",
"agreement_id": "1815",
"nct_id": "NCT00330668",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Each investigator may publish or report data from their own subjects. The trial data in aggregate are the property of Tercica, Inc. and may not be published without permission of Tercica, Inc. Tercica, Inc. will be the final arbitrator of issues relating to the publication or presentation of the aggregate data.'"
},
{
"ID": "1364",
"agreement_id": "1816",
"nct_id": "NCT00330733",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1365",
"agreement_id": "1817",
"nct_id": "NCT00265889",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1366",
"agreement_id": "1818",
"nct_id": "NCT00266032",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bayer Schering Pharma (BSP AG) coordinates publishing of study results. Principal investigators (PIs) provide BSP AG with a draft at least 90 days prior to date of planned submission or presentation. BSP AG shall have 60 days to recommend any changes. BSP AG can prevent or delay publication by informing PIs within 60 days of BSP AG\u00b4s receipt of the document about to be published. PIs shall not publish press releases\/other public statements about study\/study drug without BSP AG\u00b4s written consent.'"
},
{
"ID": "1367",
"agreement_id": "1819",
"nct_id": "NCT00266227",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1368",
"agreement_id": "1820",
"nct_id": "NCT00266279",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1369",
"agreement_id": "1821",
"nct_id": "NCT00266409",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1370",
"agreement_id": "1822",
"nct_id": "NCT00266630",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1371",
"agreement_id": "1823",
"nct_id": "NCT00266799",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If investigator wishes to publish study information, a copy of the manuscript must be provided to sponsor for review at least 60 days before submission of publication\/presentation. In the event issues arise regarding scientific integrity\/regulatory compliance, sponsor will review these issues with investigator. Investigator will not publish data derived from the individual site until 12 months after conclusion\/abandonment\/termination of study at all sites.'"
},
{
"ID": "1372",
"agreement_id": "1824",
"nct_id": "NCT00266812",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1373",
"agreement_id": "2121",
"nct_id": "NCT00264147",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1374",
"agreement_id": "2122",
"nct_id": "NCT00264290",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1375",
"agreement_id": "2123",
"nct_id": "NCT00264303",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1376",
"agreement_id": "2124",
"nct_id": "NCT00264381",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1377",
"agreement_id": "1886",
"nct_id": "NCT00319254",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1378",
"agreement_id": "1887",
"nct_id": "NCT00319436",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1379",
"agreement_id": "1888",
"nct_id": "NCT00336284",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator agrees to provide copies of any abstracts, papers or manuscripts to the Sponsor for review within a reasonable period prior to submittal for publication. BIOTRONIK limits its review to a determination of whether Confidential Information (CI) is disclosed and may not attempt to censor or in any way interfere with the investigator's presentation or conclusions beyond the extent necessary to protect CI or to allow to protect its rights in patentable or copyrightable material.'"
},
{
"ID": "1380",
"agreement_id": "1889",
"nct_id": "NCT00336323",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1381",
"agreement_id": "1890",
"nct_id": "NCT00336479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1382",
"agreement_id": "1891",
"nct_id": "NCT00249873",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.'"
},
{
"ID": "1383",
"agreement_id": "2373",
"nct_id": "NCT00306592",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.'"
},
{
"ID": "1384",
"agreement_id": "2374",
"nct_id": "NCT00306787",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1385",
"agreement_id": "2196",
"nct_id": "NCT00318136",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1386",
"agreement_id": "2197",
"nct_id": "NCT00333619",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1387",
"agreement_id": "2198",
"nct_id": "NCT00333710",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1388",
"agreement_id": "2199",
"nct_id": "NCT00333788",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1389",
"agreement_id": "2200",
"nct_id": "NCT00333801",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1390",
"agreement_id": "2201",
"nct_id": "NCT00333814",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1391",
"agreement_id": "2202",
"nct_id": "NCT00333840",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1392",
"agreement_id": "2203",
"nct_id": "NCT00333866",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1393",
"agreement_id": "1607",
"nct_id": "NCT00325416",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1394",
"agreement_id": "1608",
"nct_id": "NCT00325442",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1395",
"agreement_id": "1609",
"nct_id": "NCT00265122",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1396",
"agreement_id": "1610",
"nct_id": "NCT00265239",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1397",
"agreement_id": "1611",
"nct_id": "NCT00265317",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1398",
"agreement_id": "1612",
"nct_id": "NCT00265330",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1399",
"agreement_id": "1613",
"nct_id": "NCT00265343",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication\/presentation of data may not be made without prior review and comment by the Sponsor; all reasonable comments of Sponsor will be incorporated as far as the scientific data content is not impaired. A complete copy shall be provided to the Sponsor at least 60 days prior to date of submission. Participation in the Study involves a commitment to publish data from the study in a cooperative publication prior to publication\/presentation or on an individual basis.'"
},
{
"ID": "1400",
"agreement_id": "1614",
"nct_id": "NCT00265382",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1401",
"agreement_id": "1661",
"nct_id": "NCT00289757",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1402",
"agreement_id": "1662",
"nct_id": "NCT00289770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1403",
"agreement_id": "1825",
"nct_id": "NCT00297492",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1404",
"agreement_id": "1826",
"nct_id": "NCT00297596",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "1405",
"agreement_id": "1827",
"nct_id": "NCT00297648",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1406",
"agreement_id": "1828",
"nct_id": "NCT00297778",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1407",
"agreement_id": "1829",
"nct_id": "NCT00298090",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1408",
"agreement_id": "1830",
"nct_id": "NCT00298233",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1409",
"agreement_id": "1831",
"nct_id": "NCT00298272",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A copy of the disclosure must be given to Biogen Idec for review at least 60 days before disclosure to another party. For multi-center studies, no disclosure is permitted until results from all centers have been received and analyzed, or the study has been abandoned at all centers. If a committee of Investigators is formed for results publication, no separate publication is permitted until the initial committee publication or until a decision is reached by the committee not to publish.'"
},
{
"ID": "1410",
"agreement_id": "1832",
"nct_id": "NCT00298363",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:'"
},
{
"ID": "1411",
"agreement_id": "The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1412",
"agreement_id": "The study has been completed at all study sites for at least 2 years'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1413",
"agreement_id": "1833",
"nct_id": "NCT00298558",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1414",
"agreement_id": "1834",
"nct_id": "NCT00298766",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1415",
"agreement_id": "2047",
"nct_id": "NCT00317239",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1416",
"agreement_id": "2048",
"nct_id": "NCT00317642",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "1417",
"agreement_id": "2049",
"nct_id": "NCT00239681",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1418",
"agreement_id": "2050",
"nct_id": "NCT00239720",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1419",
"agreement_id": "2051",
"nct_id": "NCT00239837",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1420",
"agreement_id": "2137",
"nct_id": "NCT00292188",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1421",
"agreement_id": "2138",
"nct_id": "NCT00292227",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1422",
"agreement_id": "2139",
"nct_id": "NCT00292318",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1423",
"agreement_id": "2140",
"nct_id": "NCT00292370",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1424",
"agreement_id": "2141",
"nct_id": "NCT00292461",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1425",
"agreement_id": "2142",
"nct_id": "NCT00292981",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.'"
},
{
"ID": "1426",
"agreement_id": "2204",
"nct_id": "NCT00333879",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1427",
"agreement_id": "2205",
"nct_id": "NCT00333970",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1428",
"agreement_id": "2206",
"nct_id": "NCT00333983",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1429",
"agreement_id": "2207",
"nct_id": "NCT00244621",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1430",
"agreement_id": "2258",
"nct_id": "NCT00275821",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1431",
"agreement_id": "2259",
"nct_id": "NCT00275834",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1432",
"agreement_id": "2260",
"nct_id": "NCT00297258",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1433",
"agreement_id": "2261",
"nct_id": "NCT00245635",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1434",
"agreement_id": "2262",
"nct_id": "NCT00245856",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1435",
"agreement_id": "2263",
"nct_id": "NCT00245960",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1436",
"agreement_id": "2264",
"nct_id": "NCT00246012",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1437",
"agreement_id": "1663",
"nct_id": "NCT00289783",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1438",
"agreement_id": "1664",
"nct_id": "NCT00289848",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1439",
"agreement_id": "1665",
"nct_id": "NCT00289874",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1440",
"agreement_id": "1666",
"nct_id": "NCT00289887",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1441",
"agreement_id": "1667",
"nct_id": "NCT00289913",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. SPONSOR review can be expedited to meet publication guidelines.'"
},
{
"ID": "1442",
"agreement_id": "1668",
"nct_id": "NCT00289978",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1443",
"agreement_id": "1669",
"nct_id": "NCT00289991",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1444",
"agreement_id": "1670",
"nct_id": "NCT00330915",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1445",
"agreement_id": "1671",
"nct_id": "NCT00330928",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1446",
"agreement_id": "1672",
"nct_id": "NCT00330967",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1447",
"agreement_id": "1835",
"nct_id": "NCT00299000",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first publication of the results shall be made by the Sponsor in a joint publication. If such a multicenter publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from site individually, subject however to comply with the other terms of the agreement.'"
},
{
"ID": "1448",
"agreement_id": "1836",
"nct_id": "NCT00299104",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1449",
"agreement_id": "2064",
"nct_id": "NCT00309751",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1450",
"agreement_id": "2065",
"nct_id": "NCT00327171",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study, for review and comment at least 45 days in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).'"
},
{
"ID": "1451",
"agreement_id": "2066",
"nct_id": "NCT00327340",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "All investigators had an agreement with the Canadian Urological Oncology Group (CUOG). The investigators were to provide CUOG with text to be presented or published 45 days prior to the release for review. Results from one institution were not to be presented before the multi-center publication. If there is no multi-center publication within 12 months after the Study completion the Investigator had the right to publish the results.'"
},
{
"ID": "1452",
"agreement_id": "2067",
"nct_id": "NCT00327392",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1453",
"agreement_id": "2068",
"nct_id": "NCT00327444",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).'"
},
{
"ID": "1454",
"agreement_id": "2069",
"nct_id": "NCT00327470",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1455",
"agreement_id": "2070",
"nct_id": "NCT00327717",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1456",
"agreement_id": "2071",
"nct_id": "NCT00328042",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1457",
"agreement_id": "1892",
"nct_id": "NCT00250432",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1458",
"agreement_id": "1893",
"nct_id": "NCT00250458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1459",
"agreement_id": "1894",
"nct_id": "NCT00250497",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1460",
"agreement_id": "1895",
"nct_id": "NCT00250588",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1461",
"agreement_id": "1896",
"nct_id": "NCT00250679",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.'"
},
{
"ID": "1462",
"agreement_id": "2005",
"nct_id": "NCT00238355",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1463",
"agreement_id": "2006",
"nct_id": "NCT00238615",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1464",
"agreement_id": "2007",
"nct_id": "NCT00239005",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1465",
"agreement_id": "2008",
"nct_id": "NCT00239226",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "INVESTIGATOR may publish\/present the results of the work. However, INVESTIGATOR shall provide copies of any abstracts, or manuscripts to the sponsor for review at least 30 (thirty) days prior to submittal for publication or presentation. The sponsor shall limit its review to a determination of whether Confidential Information is disclosed and to check for technical correctness. Sponsor shall not attempt to censor or in any way interfere with INVESTIGATOR\u2019s presentation or conclusions.'"
},
{
"ID": "1466",
"agreement_id": "2009",
"nct_id": "NCT00239356",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1467",
"agreement_id": "2265",
"nct_id": "NCT00246025",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1468",
"agreement_id": "2266",
"nct_id": "NCT00246090",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1469",
"agreement_id": "2267",
"nct_id": "NCT00246259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1470",
"agreement_id": "2268",
"nct_id": "NCT00246324",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1471",
"agreement_id": "2269",
"nct_id": "NCT00246337",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1472",
"agreement_id": "2319",
"nct_id": "NCT00283868",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1473",
"agreement_id": "2320",
"nct_id": "NCT00284050",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1474",
"agreement_id": "2321",
"nct_id": "NCT00284089",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1475",
"agreement_id": "2322",
"nct_id": "NCT00284141",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).'"
},
{
"ID": "1476",
"agreement_id": "2323",
"nct_id": "NCT00284154",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "1477",
"agreement_id": "1673",
"nct_id": "NCT00331006",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Baxter donated Factor VIII and Genentech donated rituximab for the study. Both Baxter and Genentech can review results communications prior to public release for a period of time less than or equal to 60 days from the time submitted to them for review. These companies cannot require changes to the communication.'"
},
{
"ID": "1478",
"agreement_id": "1674",
"nct_id": "NCT00331409",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1479",
"agreement_id": "1675",
"nct_id": "NCT00331422",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1480",
"agreement_id": "1676",
"nct_id": "NCT00331682",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1481",
"agreement_id": "1677",
"nct_id": "NCT00331760",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1482",
"agreement_id": "1678",
"nct_id": "NCT00331799",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1483",
"agreement_id": "1679",
"nct_id": "NCT00331864",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1484",
"agreement_id": "1680",
"nct_id": "NCT00332189",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The first publication of the results shall be made in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however, to compliance with the other terms of the agreement.'"
},
{
"ID": "1485",
"agreement_id": "1681",
"nct_id": "NCT00332241",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1486",
"agreement_id": "1682",
"nct_id": "NCT00271024",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1487",
"agreement_id": "1683",
"nct_id": "NCT00229658",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1488",
"agreement_id": "2072",
"nct_id": "NCT00328094",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1489",
"agreement_id": "2073",
"nct_id": "NCT00328172",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1490",
"agreement_id": "2074",
"nct_id": "NCT00328198",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In multi-site studies, PI can publish after an independent multi-investigator publication (in which the PI can participate) or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.'"
},
{
"ID": "1491",
"agreement_id": "1837",
"nct_id": "NCT00247676",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1492",
"agreement_id": "1838",
"nct_id": "NCT00247962",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1493",
"agreement_id": "1839",
"nct_id": "NCT00248547",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1494",
"agreement_id": "1840",
"nct_id": "NCT00248560",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1495",
"agreement_id": "1841",
"nct_id": "NCT00248638",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1496",
"agreement_id": "1842",
"nct_id": "NCT00248651",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1497",
"agreement_id": "1843",
"nct_id": "NCT00248781",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1498",
"agreement_id": "1844",
"nct_id": "NCT00248807",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1499",
"agreement_id": "2010",
"nct_id": "NCT00239642",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1500",
"agreement_id": "2011",
"nct_id": "NCT00308308",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.'"
},
{
"ID": "1501",
"agreement_id": "2012",
"nct_id": "NCT00308516",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "1502",
"agreement_id": "2013",
"nct_id": "NCT00308555",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1503",
"agreement_id": "2014",
"nct_id": "NCT00308581",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1504",
"agreement_id": "2015",
"nct_id": "NCT00308620",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1505",
"agreement_id": "2149",
"nct_id": "NCT00274625",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1506",
"agreement_id": "2150",
"nct_id": "NCT00296322",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1507",
"agreement_id": "2151",
"nct_id": "NCT00296335",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1508",
"agreement_id": "2152",
"nct_id": "NCT00296374",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1509",
"agreement_id": "2324",
"nct_id": "NCT00284180",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "1510",
"agreement_id": "2325",
"nct_id": "NCT00284518",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1511",
"agreement_id": "2326",
"nct_id": "NCT00329108",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1512",
"agreement_id": "2327",
"nct_id": "NCT00329160",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1513",
"agreement_id": "2328",
"nct_id": "NCT00329238",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1514",
"agreement_id": "2329",
"nct_id": "NCT00329407",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1515",
"agreement_id": "2375",
"nct_id": "NCT00306891",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site or an Investigator requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "1516",
"agreement_id": "2376",
"nct_id": "NCT00306917",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1517",
"agreement_id": "2377",
"nct_id": "NCT00407966",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1518",
"agreement_id": "2378",
"nct_id": "NCT00408070",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1519",
"agreement_id": "2379",
"nct_id": "NCT00408200",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1520",
"agreement_id": "1684",
"nct_id": "NCT00229723",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent applications.'"
},
{
"ID": "1521",
"agreement_id": "1685",
"nct_id": "NCT00229957",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1522",
"agreement_id": "1686",
"nct_id": "NCT00229970",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1523",
"agreement_id": "1687",
"nct_id": "NCT00230009",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1524",
"agreement_id": "1688",
"nct_id": "NCT00230022",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1525",
"agreement_id": "1689",
"nct_id": "NCT00230048",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1526",
"agreement_id": "1690",
"nct_id": "NCT00230126",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1527",
"agreement_id": "1691",
"nct_id": "NCT00230178",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish\/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation\/publication for comment at least 30 days before any presentation\/submission for publication. If requested by the Sponsor, any presentation\/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.'"
},
{
"ID": "1528",
"agreement_id": "1692",
"nct_id": "NCT00230282",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1529",
"agreement_id": "1693",
"nct_id": "NCT00230971",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1530",
"agreement_id": "1694",
"nct_id": "NCT00231062",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If requested by Sponsor, Investigator(s) shall delay the submission of any publication or presentation for up to sixty (60) days from the date of Sponsor\u2019s request to permit the preparation and filing of related patent applications by Sponsor or for Sponsor to take other steps to protect its intellectual property interests.'"
},
{
"ID": "1531",
"agreement_id": "1845",
"nct_id": "NCT00249002",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Study data will not be published in part before the complete multicenter data has been reported in full, unless more than 1 year has elapsed since completion of the Study.'"
},
{
"ID": "1532",
"agreement_id": "Investigator\/institution must supply copy of presentation or publication to Celgene within 30 days of submission for publication. Celgene may request in writing within that 30 days that Celgene Confidential Information be deleted or be granted a 60 day delay prior to publication to permit intellectual property filings.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1533",
"agreement_id": "1846",
"nct_id": "NCT00249249",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1534",
"agreement_id": "1847",
"nct_id": "NCT00249288",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1535",
"agreement_id": "1848",
"nct_id": "NCT00249613",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1536",
"agreement_id": "1956",
"nct_id": "NCT00237666",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1537",
"agreement_id": "1957",
"nct_id": "NCT00237692",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1538",
"agreement_id": "1958",
"nct_id": "NCT00286468",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1539",
"agreement_id": "1959",
"nct_id": "NCT00286494",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1540",
"agreement_id": "1960",
"nct_id": "NCT00286728",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1541",
"agreement_id": "1961",
"nct_id": "NCT00286741",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1542",
"agreement_id": "1962",
"nct_id": "NCT00286754",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1543",
"agreement_id": "2153",
"nct_id": "NCT00296400",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1544",
"agreement_id": "2154",
"nct_id": "NCT00296491",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1545",
"agreement_id": "2155",
"nct_id": "NCT00296504",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1546",
"agreement_id": "2156",
"nct_id": "NCT00243243",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1547",
"agreement_id": "2157",
"nct_id": "NCT00243269",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1548",
"agreement_id": "2158",
"nct_id": "NCT00243347",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "1549",
"agreement_id": "2159",
"nct_id": "NCT00243386",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Baxter\u2019s agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or \u22642 years after study completion. Baxter requires a review of results communications (e.g., for confidential information) \u226560 days prior to submission or communication. Baxter may request an additional delay of \u226460 days (e.g., intellectual property protection)'"
},
{
"ID": "1550",
"agreement_id": "2160",
"nct_id": "NCT00243412",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1551",
"agreement_id": "1897",
"nct_id": "NCT00250718",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1552",
"agreement_id": "1898",
"nct_id": "NCT00250835",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1553",
"agreement_id": "1899",
"nct_id": "NCT00251004",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1554",
"agreement_id": "2380",
"nct_id": "NCT00408317",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Restrictions may vary in accordance with each agreement that is negotiated with individual investigators. Sponsor will allow publication after multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor\u2019s confidential information be removed from any publication and defer publication for period of time to allow Sponsor to obtain patent or other intellectual property right protection.'"
},
{
"ID": "1555",
"agreement_id": "2381",
"nct_id": "NCT00408421",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1556",
"agreement_id": "2382",
"nct_id": "NCT00408629",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Abbott requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. Abbott requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if Abbott needs to secure patent or proprietary protection.'"
},
{
"ID": "1557",
"agreement_id": "2383",
"nct_id": "NCT00408694",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1558",
"agreement_id": "2384",
"nct_id": "NCT00356057",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.'"
},
{
"ID": "1559",
"agreement_id": "2385",
"nct_id": "NCT00356122",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 60 days in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.'"
},
{
"ID": "1560",
"agreement_id": "2208",
"nct_id": "NCT00244712",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1561",
"agreement_id": "2209",
"nct_id": "NCT00244764",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1562",
"agreement_id": "2210",
"nct_id": "NCT00244881",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1563",
"agreement_id": "2211",
"nct_id": "NCT00244933",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1564",
"agreement_id": "1695",
"nct_id": "NCT00231114",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1565",
"agreement_id": "1696",
"nct_id": "NCT00262067",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1566",
"agreement_id": "1697",
"nct_id": "NCT00262080",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial\u2019s primary publication.'"
},
{
"ID": "1567",
"agreement_id": "1698",
"nct_id": "NCT00262119",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1568",
"agreement_id": "1699",
"nct_id": "NCT00262223",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1569",
"agreement_id": "1700",
"nct_id": "NCT00262301",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to its submission or disclosure. The sponsor may request to delete information identified by sponsor as confidential information prior to submitting such manuscript and\/or abstract for publication. For a multi-center study, the investigator must wait (i) at least 24 months after the study is completed at all sites or (ii) until after the multi-center publication.'"
},
{
"ID": "1570",
"agreement_id": "1701",
"nct_id": "NCT00284557",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1571",
"agreement_id": "1702",
"nct_id": "NCT00284739",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1572",
"agreement_id": "1703",
"nct_id": "NCT00284856",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The SPONSOR must have the opportunity to review all proposed abstracts,'"
},
{
"ID": "1573",
"agreement_id": "manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. Any information identified by the SPONSOR as'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1574",
"agreement_id": "confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1575",
"agreement_id": "1704",
"nct_id": "NCT00284934",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1576",
"agreement_id": "1705",
"nct_id": "NCT00285012",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1577",
"agreement_id": "1963",
"nct_id": "NCT00287053",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1578",
"agreement_id": "1964",
"nct_id": "NCT00287079",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1579",
"agreement_id": "1965",
"nct_id": "NCT00287222",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1580",
"agreement_id": "1966",
"nct_id": "NCT00287339",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1581",
"agreement_id": "1967",
"nct_id": "NCT00287716",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1582",
"agreement_id": "1968",
"nct_id": "NCT00287729",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1583",
"agreement_id": "1969",
"nct_id": "NCT00287872",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1584",
"agreement_id": "2075",
"nct_id": "NCT00267202",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1585",
"agreement_id": "2076",
"nct_id": "NCT00267293",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1586",
"agreement_id": "2077",
"nct_id": "NCT00267488",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1587",
"agreement_id": "2078",
"nct_id": "NCT00267631",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1588",
"agreement_id": "2079",
"nct_id": "NCT00267644",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1589",
"agreement_id": "2080",
"nct_id": "NCT00267670",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1590",
"agreement_id": "1900",
"nct_id": "NCT00251303",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1591",
"agreement_id": "1901",
"nct_id": "NCT00251316",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1592",
"agreement_id": "1902",
"nct_id": "NCT00251589",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1593",
"agreement_id": "1903",
"nct_id": "NCT00235833",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Disclosure agreements vary; most restrictive agreement states Medical Institution shall not disclose materials\/information disclosed by Abbott Japan in connection with the Clinical Research, or information obtained by conducting the Clinical Research, to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting the Clinical Research, Medical Institution shall obtain Abbott Japan's prior written approval.'"
},
{
"ID": "1594",
"agreement_id": "1904",
"nct_id": "NCT00262639",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1595",
"agreement_id": "1905",
"nct_id": "NCT00262730",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1596",
"agreement_id": "1906",
"nct_id": "NCT00262743",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1597",
"agreement_id": "1907",
"nct_id": "NCT00262834",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1598",
"agreement_id": "1908",
"nct_id": "NCT00262847",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1599",
"agreement_id": "2016",
"nct_id": "NCT00308711",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1600",
"agreement_id": "2017",
"nct_id": "NCT00308737",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.'"
},
{
"ID": "1601",
"agreement_id": "2212",
"nct_id": "NCT00245011",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1602",
"agreement_id": "2213",
"nct_id": "NCT00245050",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1603",
"agreement_id": "2214",
"nct_id": "NCT00245063",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1604",
"agreement_id": "2215",
"nct_id": "NCT00245102",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1605",
"agreement_id": "2216",
"nct_id": "NCT00245128",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1606",
"agreement_id": "2217",
"nct_id": "NCT00245466",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "1607",
"agreement_id": "2218",
"nct_id": "NCT00245557",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1608",
"agreement_id": "2219",
"nct_id": "NCT00245570",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1609",
"agreement_id": "2270",
"nct_id": "NCT00246519",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1610",
"agreement_id": "2271",
"nct_id": "NCT00246571",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1611",
"agreement_id": "2272",
"nct_id": "NCT00283400",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1612",
"agreement_id": "1706",
"nct_id": "NCT00285207",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1613",
"agreement_id": "1707",
"nct_id": "NCT00285246",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1614",
"agreement_id": "1708",
"nct_id": "NCT00285584",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1615",
"agreement_id": "1709",
"nct_id": "NCT00290186",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1616",
"agreement_id": "1710",
"nct_id": "NCT00290199",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1617",
"agreement_id": "1711",
"nct_id": "NCT00311376",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1618",
"agreement_id": "1712",
"nct_id": "NCT00311402",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract'"
},
{
"ID": "1619",
"agreement_id": "1713",
"nct_id": "NCT00311584",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Must obtain prior Sponsor approval.'"
},
{
"ID": "1620",
"agreement_id": "1714",
"nct_id": "NCT00311766",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1621",
"agreement_id": "1715",
"nct_id": "NCT00312195",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1622",
"agreement_id": "1716",
"nct_id": "NCT00312208",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish\/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation\/publication for comment at least 30 days before any presentation\/submission for publication. If requested by the Sponsor, any presentation\/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.'"
},
{
"ID": "1623",
"agreement_id": "2081",
"nct_id": "NCT00267696",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1624",
"agreement_id": "2082",
"nct_id": "NCT00267748",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1625",
"agreement_id": "2083",
"nct_id": "NCT00267956",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1626",
"agreement_id": "2084",
"nct_id": "NCT00267969",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1627",
"agreement_id": "2085",
"nct_id": "NCT00268203",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1628",
"agreement_id": "2086",
"nct_id": "NCT00268346",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1629",
"agreement_id": "1849",
"nct_id": "NCT00249795",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.'"
},
{
"ID": "1630",
"agreement_id": "1850",
"nct_id": "NCT00249821",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1631",
"agreement_id": "1851",
"nct_id": "NCT00326495",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1632",
"agreement_id": "1852",
"nct_id": "NCT00326612",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1633",
"agreement_id": "1853",
"nct_id": "NCT00326716",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1634",
"agreement_id": "2018",
"nct_id": "NCT00308997",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1635",
"agreement_id": "2019",
"nct_id": "NCT00309244",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multi-center Study publication, PI may publish the Study results subject to MNKD rights herein.'"
},
{
"ID": "1636",
"agreement_id": "2020",
"nct_id": "NCT00309387",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1637",
"agreement_id": "2021",
"nct_id": "NCT00309465",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1638",
"agreement_id": "2022",
"nct_id": "NCT00309608",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1639",
"agreement_id": "2023",
"nct_id": "NCT00332488",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.'"
},
{
"ID": "1640",
"agreement_id": "2024",
"nct_id": "NCT00332579",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1641",
"agreement_id": "2025",
"nct_id": "NCT00332605",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1642",
"agreement_id": "2026",
"nct_id": "NCT00332644",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1643",
"agreement_id": "2027",
"nct_id": "NCT00332696",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Disclosure Restriction Description: The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or of the trial results in their entirety.'"
},
{
"ID": "1644",
"agreement_id": "2125",
"nct_id": "NCT00264498",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1645",
"agreement_id": "2273",
"nct_id": "NCT00283439",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1646",
"agreement_id": "2274",
"nct_id": "NCT00310427",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1647",
"agreement_id": "2275",
"nct_id": "NCT00310466",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "ALK must receive copies of any intended communication in advance of publication (at least 15 working days for an abstract or oral presentation and 45 working days for a journal submission). ALK will review the communications for accuracy (thus avoiding potential discrepancies with submissions to health authorities), verify that confidential information is not being inadvertently divulged and provide any relevant supplementary information.'"
},
{
"ID": "1648",
"agreement_id": "2276",
"nct_id": "NCT00310791",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1649",
"agreement_id": "2277",
"nct_id": "NCT00310804",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1650",
"agreement_id": "2278",
"nct_id": "NCT00310856",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigators from publishing. Any publications from a single site are postponed until the publication of the pool data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1651",
"agreement_id": "2279",
"nct_id": "NCT00311155",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1652",
"agreement_id": "2280",
"nct_id": "NCT00311181",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1653",
"agreement_id": "2281",
"nct_id": "NCT00311311",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1654",
"agreement_id": "2330",
"nct_id": "NCT00329420",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1655",
"agreement_id": "1717",
"nct_id": "NCT00312221",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1656",
"agreement_id": "1718",
"nct_id": "NCT00312338",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1657",
"agreement_id": "1719",
"nct_id": "NCT00312377",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "1658",
"agreement_id": "1720",
"nct_id": "NCT00312494",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1659",
"agreement_id": "1721",
"nct_id": "NCT00312572",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1660",
"agreement_id": "1722",
"nct_id": "NCT00271154",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In most cases, contracts allow investigators to publish study results per the publication plan\/protocol following Medtronic's review to determine whether confidential information (\u0022CI\u0022) is disclosed. Any such CI is deleted prior to publication\/presentation. Medtronic may not censor\/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred.'"
},
{
"ID": "1661",
"agreement_id": "1723",
"nct_id": "NCT00271219",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1662",
"agreement_id": "1724",
"nct_id": "NCT00271544",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, contracts allow investigators to publish study results per the protocol and publication plan. Medtronic reviews publications to determine if confidential information (\u0022CI\u0022) is included. Any such CI is deleted before publication. Medtronic may not censor\/interfere with the publication. Investigators may publish single-site publications after a decision by Medtronic that no multi-site study publication will be done or 12 months after the study is closed, whichever is earlier.'"
},
{
"ID": "1663",
"agreement_id": "1725",
"nct_id": "NCT00271570",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1664",
"agreement_id": "1726",
"nct_id": "NCT00271596",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1665",
"agreement_id": "1727",
"nct_id": "NCT00271609",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1666",
"agreement_id": "1854",
"nct_id": "NCT00326781",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1667",
"agreement_id": "1855",
"nct_id": "NCT00326872",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1668",
"agreement_id": "1856",
"nct_id": "NCT00326885",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Site may publish the results of the Study after such cooperative publication, or 1 year after Sponsor's final evaluation of all the Study data from all sites, whichever occurs first. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Fresenius Biotech at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.'"
},
{
"ID": "1669",
"agreement_id": "1857",
"nct_id": "NCT00326911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review\/redaction by sponsor. Sponsor may request publication delay up to 90 days to seek patent protection.'"
},
{
"ID": "1670",
"agreement_id": "1858",
"nct_id": "NCT00326950",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1671",
"agreement_id": "1859",
"nct_id": "NCT00327015",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1672",
"agreement_id": "1860",
"nct_id": "NCT00262314",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1673",
"agreement_id": "1970",
"nct_id": "NCT00288054",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1674",
"agreement_id": "1971",
"nct_id": "NCT00288067",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1675",
"agreement_id": "1972",
"nct_id": "NCT00288509",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "A publication of results from all sites in this multicenter study is expected. If the sponsor no longer plans this or 6 months after study completion at all sites, the PI may publish the results. He will supply any proposed publication to the sponsor for review and comment at least 30 days before submission for publication. If the sponsor believes a patent application should be filed, the publication will be delayed for another 60 days or until patent filing; with a maximum delay of 90 days.'"
},
{
"ID": "1676",
"agreement_id": "2126",
"nct_id": "NCT00264537",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1677",
"agreement_id": "2127",
"nct_id": "NCT00264550",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1678",
"agreement_id": "2128",
"nct_id": "NCT00264576",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1679",
"agreement_id": "2129",
"nct_id": "NCT00268463",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1680",
"agreement_id": "2130",
"nct_id": "NCT00291330",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the results of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1681",
"agreement_id": "2131",
"nct_id": "NCT00291551",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1682",
"agreement_id": "2132",
"nct_id": "NCT00291577",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1683",
"agreement_id": "2133",
"nct_id": "NCT00291655",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1684",
"agreement_id": "2134",
"nct_id": "NCT00291694",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1685",
"agreement_id": "2135",
"nct_id": "NCT00291876",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1686",
"agreement_id": "2136",
"nct_id": "NCT00292162",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1687",
"agreement_id": "2331",
"nct_id": "NCT00329433",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1688",
"agreement_id": "2332",
"nct_id": "NCT00329524",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1689",
"agreement_id": "2333",
"nct_id": "NCT00329550",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1690",
"agreement_id": "2334",
"nct_id": "NCT00329602",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1691",
"agreement_id": "2335",
"nct_id": "NCT00329641",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1692",
"agreement_id": "2336",
"nct_id": "NCT00329719",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1693",
"agreement_id": "2337",
"nct_id": "NCT00265096",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1694",
"agreement_id": "2338",
"nct_id": "NCT00265109",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1695",
"agreement_id": "2339",
"nct_id": "NCT00269477",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.'"
},
{
"ID": "1696",
"agreement_id": "2340",
"nct_id": "NCT00269919",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1697",
"agreement_id": "1728",
"nct_id": "NCT00271739",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1698",
"agreement_id": "1729",
"nct_id": "NCT00271817",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1699",
"agreement_id": "1730",
"nct_id": "NCT00271856",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1700",
"agreement_id": "1731",
"nct_id": "NCT00271947",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1701",
"agreement_id": "1732",
"nct_id": "NCT00272038",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1702",
"agreement_id": "1733",
"nct_id": "NCT00272311",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1703",
"agreement_id": "1734",
"nct_id": "NCT00272337",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1704",
"agreement_id": "1735",
"nct_id": "NCT00272779",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1705",
"agreement_id": "1736",
"nct_id": "NCT00231153",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1706",
"agreement_id": "1737",
"nct_id": "NCT00231179",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1707",
"agreement_id": "1738",
"nct_id": "NCT00231283",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1708",
"agreement_id": "1973",
"nct_id": "NCT00313209",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The study results may be published and\/or presented at scientific meetings. Prior to any submission, all manuscripts\/abstracts must be presented to the sponsor for possible comments.'"
},
{
"ID": "1709",
"agreement_id": "1974",
"nct_id": "NCT00313313",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1710",
"agreement_id": "1975",
"nct_id": "NCT00313443",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1711",
"agreement_id": "1976",
"nct_id": "NCT00313586",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1712",
"agreement_id": "1977",
"nct_id": "NCT00313703",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1713",
"agreement_id": "1978",
"nct_id": "NCT00313716",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1714",
"agreement_id": "1979",
"nct_id": "NCT00313781",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1715",
"agreement_id": "1980",
"nct_id": "NCT00313820",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1716",
"agreement_id": "2087",
"nct_id": "NCT00268437",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1717",
"agreement_id": "2088",
"nct_id": "NCT00336492",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1718",
"agreement_id": "2089",
"nct_id": "NCT00336505",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1719",
"agreement_id": "2090",
"nct_id": "NCT00336544",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1720",
"agreement_id": "1909",
"nct_id": "NCT00262925",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1721",
"agreement_id": "1910",
"nct_id": "NCT00262951",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1722",
"agreement_id": "1911",
"nct_id": "NCT00262964",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1723",
"agreement_id": "1912",
"nct_id": "NCT00263328",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1724",
"agreement_id": "1913",
"nct_id": "NCT00263666",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1725",
"agreement_id": "1914",
"nct_id": "NCT00263757",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1726",
"agreement_id": "1915",
"nct_id": "NCT00263887",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed within thirty days and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution, which satisfies both parties.'"
},
{
"ID": "1727",
"agreement_id": "1916",
"nct_id": "NCT00286455",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1728",
"agreement_id": "1917",
"nct_id": "NCT00290615",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1729",
"agreement_id": "1918",
"nct_id": "NCT00290654",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1730",
"agreement_id": "1919",
"nct_id": "NCT00290693",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1731",
"agreement_id": "2386",
"nct_id": "NCT00356135",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1732",
"agreement_id": "2387",
"nct_id": "NCT00356148",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1733",
"agreement_id": "2388",
"nct_id": "NCT00356200",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1734",
"agreement_id": "2389",
"nct_id": "NCT00320489",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1735",
"agreement_id": "2390",
"nct_id": "NCT00320515",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1736",
"agreement_id": "2391",
"nct_id": "NCT00252564",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1737",
"agreement_id": "2392",
"nct_id": "NCT00252629",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1738",
"agreement_id": "2393",
"nct_id": "NCT00252694",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1739",
"agreement_id": "2394",
"nct_id": "NCT00252720",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1740",
"agreement_id": "2395",
"nct_id": "NCT00252733",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1741",
"agreement_id": "2396",
"nct_id": "NCT00252967",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1742",
"agreement_id": "2397",
"nct_id": "NCT00253019",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1743",
"agreement_id": "1739",
"nct_id": "NCT00231309",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1744",
"agreement_id": "1740",
"nct_id": "NCT00231465",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1745",
"agreement_id": "1741",
"nct_id": "NCT00231478",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "\u0022The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.\u0022'"
},
{
"ID": "1746",
"agreement_id": "1742",
"nct_id": "NCT00231777",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1747",
"agreement_id": "1743",
"nct_id": "NCT00231816",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1748",
"agreement_id": "1744",
"nct_id": "NCT00232141",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1749",
"agreement_id": "1745",
"nct_id": "NCT00232180",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1750",
"agreement_id": "1746",
"nct_id": "NCT00232479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1751",
"agreement_id": "1747",
"nct_id": "NCT00232544",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1752",
"agreement_id": "1748",
"nct_id": "NCT00232557",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1753",
"agreement_id": "1749",
"nct_id": "NCT00285779",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1754",
"agreement_id": "2091",
"nct_id": "NCT00336583",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1755",
"agreement_id": "2092",
"nct_id": "NCT00336973",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1756",
"agreement_id": "2093",
"nct_id": "NCT00337077",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1757",
"agreement_id": "2094",
"nct_id": "NCT00337103",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1758",
"agreement_id": "2095",
"nct_id": "NCT00337129",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1759",
"agreement_id": "2096",
"nct_id": "NCT00337168",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1760",
"agreement_id": "2097",
"nct_id": "NCT00337194",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1761",
"agreement_id": "2098",
"nct_id": "NCT00337207",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1762",
"agreement_id": "2099",
"nct_id": "NCT00337272",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "PI must provide Sponsor an advance copy of any proposed publication whether in journals or in conferences or other public forum at least 60 days prior to any submission for publication or public presentation so that Sponsor may determine whether it contains any Confidential Information of Sponsor, and\/or any discovery or invention is made.'"
},
{
"ID": "1763",
"agreement_id": "2100",
"nct_id": "NCT00337285",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and\/or such Principal Investigator may publish the results from the Institution site individually.'"
},
{
"ID": "1764",
"agreement_id": "1861",
"nct_id": "NCT00262509",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1765",
"agreement_id": "1862",
"nct_id": "NCT00262522",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Provide ABBOTT at least thirty (30) days prior to submission for review, ABBOTT shall return comments within thirty (30) days of receipt of draft. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period'"
},
{
"ID": "1766",
"agreement_id": "1920",
"nct_id": "NCT00290732",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1767",
"agreement_id": "2028",
"nct_id": "NCT00332709",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.'"
},
{
"ID": "1768",
"agreement_id": "2029",
"nct_id": "NCT00332722",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1769",
"agreement_id": "2030",
"nct_id": "NCT00332839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.'"
},
{
"ID": "1770",
"agreement_id": "2031",
"nct_id": "NCT00333138",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1771",
"agreement_id": "2032",
"nct_id": "NCT00333229",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.'"
},
{
"ID": "1772",
"agreement_id": "2033",
"nct_id": "NCT00333359",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1773",
"agreement_id": "2034",
"nct_id": "NCT00333437",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1774",
"agreement_id": "2035",
"nct_id": "NCT00267189",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1775",
"agreement_id": "2036",
"nct_id": "NCT00296231",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1776",
"agreement_id": "2037",
"nct_id": "NCT00296244",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1777",
"agreement_id": "2398",
"nct_id": "NCT00253370",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1778",
"agreement_id": "2220",
"nct_id": "NCT00289120",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1779",
"agreement_id": "2221",
"nct_id": "NCT00289185",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1780",
"agreement_id": "2222",
"nct_id": "NCT00289211",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to sponsor for pre-review. If sponsor requests, PI must delete sponsor confidential information before publication and\/or delay publication for 90 days so sponsor can file for patents or take other action to protect its patent rights.'"
},
{
"ID": "1781",
"agreement_id": "2223",
"nct_id": "NCT00289276",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In most cases, contracts allow investigators (\u0022PI\u0022) to publish per the publication strategy\/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (\u0022CI\u0022), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication\/presentation. Medtronic may not otherwise censor\/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred.'"
},
{
"ID": "1782",
"agreement_id": "2224",
"nct_id": "NCT00289289",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1783",
"agreement_id": "2225",
"nct_id": "NCT00289341",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1784",
"agreement_id": "2226",
"nct_id": "NCT00289458",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1785",
"agreement_id": "2227",
"nct_id": "NCT00289471",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1786",
"agreement_id": "2228",
"nct_id": "NCT00309777",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1787",
"agreement_id": "2229",
"nct_id": "NCT00309907",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1788",
"agreement_id": "1750",
"nct_id": "NCT00286091",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1789",
"agreement_id": "1751",
"nct_id": "NCT00286156",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1790",
"agreement_id": "1752",
"nct_id": "NCT00286325",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1791",
"agreement_id": "1753",
"nct_id": "NCT00286429",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1792",
"agreement_id": "1754",
"nct_id": "NCT00286442",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1793",
"agreement_id": "1755",
"nct_id": "NCT00307086",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1794",
"agreement_id": "1756",
"nct_id": "NCT00307125",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1795",
"agreement_id": "1757",
"nct_id": "NCT00307151",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscript and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "1796",
"agreement_id": "1758",
"nct_id": "NCT00307164",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1797",
"agreement_id": "1759",
"nct_id": "NCT00307333",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1798",
"agreement_id": "1863",
"nct_id": "NCT00262600",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "1799",
"agreement_id": "1864",
"nct_id": "NCT00266864",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1800",
"agreement_id": "1865",
"nct_id": "NCT00267007",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1801",
"agreement_id": "1866",
"nct_id": "NCT00267046",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1802",
"agreement_id": "1867",
"nct_id": "NCT00267059",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1803",
"agreement_id": "1868",
"nct_id": "NCT00267085",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1804",
"agreement_id": "1869",
"nct_id": "NCT00267098",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1805",
"agreement_id": "1870",
"nct_id": "NCT00267111",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1806",
"agreement_id": "1871",
"nct_id": "NCT00267150",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1807",
"agreement_id": "1872",
"nct_id": "NCT00290238",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If the PI expects to participate in the publication or presentation of data generated in the performance of the study, any reports, abstracts, manuscripts, or other presentation materials shall be submitted to the sponsor for review prior to submission for publication or presentation. The sponsor shall have 30 calendar days to respond with any requested revisions in order to protect the sponsor's confidential information.'"
},
{
"ID": "1808",
"agreement_id": "1873",
"nct_id": "NCT00290251",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1809",
"agreement_id": "2038",
"nct_id": "NCT00316264",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1810",
"agreement_id": "2039",
"nct_id": "NCT00316277",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1811",
"agreement_id": "2161",
"nct_id": "NCT00243503",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1812",
"agreement_id": "2162",
"nct_id": "NCT00243659",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "1813",
"agreement_id": "2163",
"nct_id": "NCT00243919",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1814",
"agreement_id": "2164",
"nct_id": "NCT00243932",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1815",
"agreement_id": "2165",
"nct_id": "NCT00244010",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1816",
"agreement_id": "2166",
"nct_id": "NCT00244101",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1817",
"agreement_id": "2167",
"nct_id": "NCT00244140",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1818",
"agreement_id": "2168",
"nct_id": "NCT00244374",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1819",
"agreement_id": "2169",
"nct_id": "NCT00264797",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1820",
"agreement_id": "2230",
"nct_id": "NCT00309946",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1821",
"agreement_id": "2231",
"nct_id": "NCT00310076",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1822",
"agreement_id": "2282",
"nct_id": "NCT00311363",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1823",
"agreement_id": "2283",
"nct_id": "NCT00328627",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "1824",
"agreement_id": "2284",
"nct_id": "NCT00328770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1825",
"agreement_id": "2285",
"nct_id": "NCT00328783",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1826",
"agreement_id": "2286",
"nct_id": "NCT00328861",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1827",
"agreement_id": "2287",
"nct_id": "NCT00328926",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1828",
"agreement_id": "2288",
"nct_id": "NCT00335452",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication of the study is made jointly in the name of all wholehearted collaborators. Other papers are authored based on the contributions of the individuals to the overall study. Sub-studies with scientific merit which have received prior approvals of the Steering Committee may be published separately in the names of contributing Investigators. A copy of all manuscripts are provided to the Sponsors for their review and the final decision to publish is made by the Steering Committee.'"
},
{
"ID": "1829",
"agreement_id": "2289",
"nct_id": "NCT00335478",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1830",
"agreement_id": "2290",
"nct_id": "NCT00335504",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1831",
"agreement_id": "1760",
"nct_id": "NCT00307437",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1832",
"agreement_id": "1761",
"nct_id": "NCT00312728",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and\/or the publication be postponed in order to protect the Sponsor's intellectual property rights.'"
},
{
"ID": "1833",
"agreement_id": "1762",
"nct_id": "NCT00312845",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1834",
"agreement_id": "1763",
"nct_id": "NCT00312858",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1835",
"agreement_id": "1764",
"nct_id": "NCT00329732",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1836",
"agreement_id": "1765",
"nct_id": "NCT00329745",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1837",
"agreement_id": "1766",
"nct_id": "NCT00329771",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1838",
"agreement_id": "1767",
"nct_id": "NCT00329836",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1839",
"agreement_id": "1768",
"nct_id": "NCT00329849",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1840",
"agreement_id": "1769",
"nct_id": "NCT00329901",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1841",
"agreement_id": "1770",
"nct_id": "NCT00330161",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1842",
"agreement_id": "1981",
"nct_id": "NCT00313846",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1843",
"agreement_id": "1982",
"nct_id": "NCT00313911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.'"
},
{
"ID": "1844",
"agreement_id": "1983",
"nct_id": "NCT00332332",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1845",
"agreement_id": "1984",
"nct_id": "NCT00332462",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1846",
"agreement_id": "1985",
"nct_id": "NCT00319449",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The principal investigator (PI) agrees not to publish or publicly present'"
},
{
"ID": "1847",
"agreement_id": "any interim results of the Study without prior written consent of the SPONSOR.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1848",
"agreement_id": "The PI further agrees to provide thirty (30) days written notice to the SPONSOR prior to submission for publication or presentation to allow SPONSOR to review abstracts or manuscripts for publication.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1849",
"agreement_id": "1986",
"nct_id": "NCT00319553",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.'"
},
{
"ID": "1850",
"agreement_id": "1987",
"nct_id": "NCT00319592",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.'"
},
{
"ID": "1851",
"agreement_id": "1988",
"nct_id": "NCT00319644",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1852",
"agreement_id": "1989",
"nct_id": "NCT00319696",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1853",
"agreement_id": "1990",
"nct_id": "NCT00319748",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1854",
"agreement_id": "1991",
"nct_id": "NCT00319982",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1855",
"agreement_id": "2170",
"nct_id": "NCT00264810",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Each Investigator and Institution agree that the 1st publication of study results shall be a joint, multi-center publication.'"
},
{
"ID": "1856",
"agreement_id": "Each Investigator, Coordinator, and Institution agree to submit publications to the RNS\u00ae System Study Publication Committee for review prior to submission for publication (at least 30 days for manuscripts and at least 7 days for abstracts) to assure that publication does not compromise the scientific integrity of the study or contain confidential NeuroPace information.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1857",
"agreement_id": "2171",
"nct_id": "NCT00264849",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1858",
"agreement_id": "2172",
"nct_id": "NCT00264875",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "1859",
"agreement_id": "1921",
"nct_id": "NCT00290771",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.'"
},
{
"ID": "1860",
"agreement_id": "1922",
"nct_id": "NCT00290810",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1861",
"agreement_id": "1923",
"nct_id": "NCT00290888",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1862",
"agreement_id": "1924",
"nct_id": "NCT00291135",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1863",
"agreement_id": "1925",
"nct_id": "NCT00291187",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1864",
"agreement_id": "1926",
"nct_id": "NCT00291317",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1865",
"agreement_id": "1927",
"nct_id": "NCT00312923",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1866",
"agreement_id": "1928",
"nct_id": "NCT00313014",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1867",
"agreement_id": "2291",
"nct_id": "NCT00335517",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1868",
"agreement_id": "2292",
"nct_id": "NCT00335725",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1869",
"agreement_id": "2293",
"nct_id": "NCT00335777",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1870",
"agreement_id": "2294",
"nct_id": "NCT00335959",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1871",
"agreement_id": "2341",
"nct_id": "NCT00270205",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "1872",
"agreement_id": "2342",
"nct_id": "NCT00270231",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1873",
"agreement_id": "2343",
"nct_id": "NCT00270634",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1874",
"agreement_id": "2344",
"nct_id": "NCT00270842",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1875",
"agreement_id": "2345",
"nct_id": "NCT00270894",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor shall submit to Aventis for review of confidential information and patent protection purposes, any manuscript or abstract prepared for publication at least 30 days prior to submission to publisher. Upon written request by Aventis to Sponsor within such 30 days, Sponsor agrees to delay such publication until Aventis determines that the publication will not compromise any patent rights. However, such delay shall not exceed 90 additional days.'"
},
{
"ID": "1876",
"agreement_id": "2346",
"nct_id": "NCT00271011",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1877",
"agreement_id": "2347",
"nct_id": "NCT00293241",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1878",
"agreement_id": "1771",
"nct_id": "NCT00330174",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1879",
"agreement_id": "1772",
"nct_id": "NCT00330382",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1880",
"agreement_id": "1773",
"nct_id": "NCT00330421",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1881",
"agreement_id": "1774",
"nct_id": "NCT00294645",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In most cases, contracts allow investigators (\u0022PI\u0022) to publish per the publication strategy\/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (\u0022CI\u0022), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication\/presentation. Medtronic may not otherwise censor\/interfere with the publication. PIs may not publish single-site data until the main multi-site publication has occurred.'"
},
{
"ID": "1882",
"agreement_id": "1775",
"nct_id": "NCT00294723",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Novo Nordisk reserves the right to not release data until specified milestones. This includes the right to not release interim results, because the release of such information can invalidate the results of the entire trial. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and\/or communication for less than 60 days to protect intellectual property.'"
},
{
"ID": "1883",
"agreement_id": "1776",
"nct_id": "NCT00294762",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1884",
"agreement_id": "1777",
"nct_id": "NCT00295009",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1885",
"agreement_id": "1778",
"nct_id": "NCT00295061",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.'"
},
{
"ID": "1886",
"agreement_id": "1779",
"nct_id": "NCT00295490",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1887",
"agreement_id": "1780",
"nct_id": "NCT00295633",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "1888",
"agreement_id": "1992",
"nct_id": "NCT00320112",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1889",
"agreement_id": "2101",
"nct_id": "NCT00274651",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1890",
"agreement_id": "2102",
"nct_id": "NCT00274716",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication\/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.'"
},
{
"ID": "1891",
"agreement_id": "2103",
"nct_id": "NCT00241644",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1892",
"agreement_id": "2104",
"nct_id": "NCT00241839",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1893",
"agreement_id": "2105",
"nct_id": "NCT00242216",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1894",
"agreement_id": "2106",
"nct_id": "NCT00242385",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Baxter's agreements with PIs vary per individual PI, but contain common elements. Baxter requires a review of results communications (e.g., for confidential information) \u226560 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (e.g., to allow for intellectual property protection).'"
},
{
"ID": "1895",
"agreement_id": "2107",
"nct_id": "NCT00242502",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1896",
"agreement_id": "2108",
"nct_id": "NCT00242567",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1897",
"agreement_id": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "1898",
"agreement_id": "2109",
"nct_id": "NCT00242580",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "1899",
"agreement_id": "2110",
"nct_id": "NCT00242658",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1900",
"agreement_id": "1929",
"nct_id": "NCT00313144",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Baxter's agreements with PIs vary per individual PI, but contain common elements. Baxter may require a review of results communications (e.g., for confidential information & intellectual property) \u226545 days prior to submission or communication for review and comment. Baxter reserves the right to remove all confidential information from all publications.'"
},
{
"ID": "1901",
"agreement_id": "1930",
"nct_id": "NCT00313170",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1902",
"agreement_id": "1931",
"nct_id": "NCT00334061",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1903",
"agreement_id": "1932",
"nct_id": "NCT00334074",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1904",
"agreement_id": "2040",
"nct_id": "NCT00316303",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1905",
"agreement_id": "2041",
"nct_id": "NCT00316693",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1906",
"agreement_id": "2042",
"nct_id": "NCT00316706",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1907",
"agreement_id": "2043",
"nct_id": "NCT00316719",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1908",
"agreement_id": "2044",
"nct_id": "NCT00316914",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1909",
"agreement_id": "2045",
"nct_id": "NCT00317044",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1910",
"agreement_id": "2046",
"nct_id": "NCT00317226",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1911",
"agreement_id": "2348",
"nct_id": "NCT00293254",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial, but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1912",
"agreement_id": "2349",
"nct_id": "NCT00293267",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1913",
"agreement_id": "2350",
"nct_id": "NCT00293293",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1914",
"agreement_id": "2351",
"nct_id": "NCT00293384",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1915",
"agreement_id": "2352",
"nct_id": "NCT00224874",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1916",
"agreement_id": "1479",
"nct_id": "NCT00210639",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1917",
"agreement_id": "1480",
"nct_id": "NCT00211081",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1918",
"agreement_id": "1481",
"nct_id": "NCT00211172",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1919",
"agreement_id": "1482",
"nct_id": "NCT00211237",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1920",
"agreement_id": "1483",
"nct_id": "NCT00211510",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1921",
"agreement_id": "1484",
"nct_id": "NCT00211536",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1922",
"agreement_id": "1781",
"nct_id": "NCT00295750",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.'"
},
{
"ID": "1923",
"agreement_id": "1782",
"nct_id": "NCT00295854",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1924",
"agreement_id": "1783",
"nct_id": "NCT00295880",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1925",
"agreement_id": "1784",
"nct_id": "NCT00296192",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1926",
"agreement_id": "1785",
"nct_id": "NCT00232583",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1927",
"agreement_id": "1786",
"nct_id": "NCT00232596",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1928",
"agreement_id": "1787",
"nct_id": "NCT00232739",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1929",
"agreement_id": "1788",
"nct_id": "NCT00233064",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1930",
"agreement_id": "1789",
"nct_id": "NCT00233324",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1931",
"agreement_id": "1790",
"nct_id": "NCT00233402",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1932",
"agreement_id": "1791",
"nct_id": "NCT00233454",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1933",
"agreement_id": "2111",
"nct_id": "NCT00242684",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1934",
"agreement_id": "2112",
"nct_id": "NCT00242710",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "1935",
"agreement_id": "1874",
"nct_id": "NCT00290290",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1936",
"agreement_id": "1875",
"nct_id": "NCT00290407",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1937",
"agreement_id": "1876",
"nct_id": "NCT00290472",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1938",
"agreement_id": "1877",
"nct_id": "NCT00290537",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1939",
"agreement_id": "1878",
"nct_id": "NCT00318565",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1940",
"agreement_id": "1879",
"nct_id": "NCT00318591",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1941",
"agreement_id": "1880",
"nct_id": "NCT00318656",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1942",
"agreement_id": "1881",
"nct_id": "NCT00318708",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1943",
"agreement_id": "1882",
"nct_id": "NCT00318812",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1944",
"agreement_id": "2246",
"nct_id": "NCT00335322",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1945",
"agreement_id": "2247",
"nct_id": "NCT00274742",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "1946",
"agreement_id": "2248",
"nct_id": "NCT00274768",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1947",
"agreement_id": "2249",
"nct_id": "NCT00274781",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1948",
"agreement_id": "2250",
"nct_id": "NCT00274846",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1949",
"agreement_id": "2251",
"nct_id": "NCT00274924",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1950",
"agreement_id": "2252",
"nct_id": "NCT00275002",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1951",
"agreement_id": "2253",
"nct_id": "NCT00275262",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Abbott requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. Abbott requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if Abbott needs to secure patent or proprietary protection.'"
},
{
"ID": "1952",
"agreement_id": "2254",
"nct_id": "NCT00275275",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1953",
"agreement_id": "2255",
"nct_id": "NCT00275340",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1954",
"agreement_id": "2256",
"nct_id": "NCT00275392",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1955",
"agreement_id": "1485",
"nct_id": "NCT00211692",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1956",
"agreement_id": "1486",
"nct_id": "NCT00211887",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1957",
"agreement_id": "1487",
"nct_id": "NCT00212134",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1958",
"agreement_id": "1488",
"nct_id": "NCT00212355",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.'"
},
{
"ID": "1959",
"agreement_id": "1489",
"nct_id": "NCT00212758",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1960",
"agreement_id": "1490",
"nct_id": "NCT00213135",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "1961",
"agreement_id": "1491",
"nct_id": "NCT00214201",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1962",
"agreement_id": "1544",
"nct_id": "NCT00203047",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor has the right 60 days before submission for publication to review\/provide comments. If the Sponsor\u2019s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor\u2019s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.'"
},
{
"ID": "1963",
"agreement_id": "1545",
"nct_id": "NCT00203203",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1964",
"agreement_id": "1546",
"nct_id": "NCT00203216",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1965",
"agreement_id": "1547",
"nct_id": "NCT00203229",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1966",
"agreement_id": "1548",
"nct_id": "NCT00203242",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1967",
"agreement_id": "1792",
"nct_id": "NCT00233519",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "National Institutes of Health (NIH) can review the content of planned submissions prior to public release (3 weeks notice requested) to insure integrity of the NIH and the Data Safety Monitoring Board (DMSB)staff.'"
},
{
"ID": "1968",
"agreement_id": "1793",
"nct_id": "NCT00246805",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "should INVESTIGATOR contemplate publishing\/presenting, he shall provide copies of any abstracts, papers, or manuscripts to sponsor for review at least 30 days prior to submittal for publication or presentation. Sponsor shall limit its review to a determination of whether Confidential Information is disclosed and to check for technical correctness and shall not attempt to censor or in any way interfere with PARTICIPATING INSTITUTION\u2019s or INVESTIGATOR\u2019s presentation or conclusions'"
},
{
"ID": "1969",
"agreement_id": "1794",
"nct_id": "NCT00247273",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1970",
"agreement_id": "1795",
"nct_id": "NCT00247377",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1971",
"agreement_id": "1796",
"nct_id": "NCT00247416",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1972",
"agreement_id": "1797",
"nct_id": "NCT00247611",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1973",
"agreement_id": "1798",
"nct_id": "NCT00307489",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1974",
"agreement_id": "1799",
"nct_id": "NCT00307684",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1975",
"agreement_id": "1800",
"nct_id": "NCT00307801",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Schering AG is interested in the publication of the results of every study. As some of the information concerning the study drug and development activities at Schering AG may be of strictly confidential nature, any publication manuscript must first be reviewed by the sponsor before its submission or presentation.'"
},
{
"ID": "1976",
"agreement_id": "1801",
"nct_id": "NCT00307931",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.'"
},
{
"ID": "1977",
"agreement_id": "1802",
"nct_id": "NCT00308087",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Investigator agrees to provide sponsor with an advance copy of any proposed publication or presentation at least 60 days prior to the planned submission or presentation. Genzyme shall have 30 days in which to recommend changes and to inform investigator if confidential information is contained. In the event of the latter, investigator will delay or prevent publication for no more that 90 days to permit sponsor to file a patent application.'"
},
{
"ID": "1978",
"agreement_id": "1883",
"nct_id": "NCT00318929",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1979",
"agreement_id": "1884",
"nct_id": "NCT00319046",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1980",
"agreement_id": "1885",
"nct_id": "NCT00319111",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Results from multi-center studies must be published or presented at congresses only in their entirety and not as individual center data, except for ancillary studies. Any study-related article or abstract written independently by investigators should be submitted to Actelion for review at least 60 days prior to submission for publication or presentation.'"
},
{
"ID": "1981",
"agreement_id": "1993",
"nct_id": "NCT00320190",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial\u2019s primary publication'"
},
{
"ID": "1982",
"agreement_id": "1994",
"nct_id": "NCT00320216",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1983",
"agreement_id": "1995",
"nct_id": "NCT00320281",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1984",
"agreement_id": "1996",
"nct_id": "NCT00320385",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1985",
"agreement_id": "1997",
"nct_id": "NCT00320411",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "1986",
"agreement_id": "1998",
"nct_id": "NCT00237718",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1987",
"agreement_id": "1999",
"nct_id": "NCT00237744",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1988",
"agreement_id": "2000",
"nct_id": "NCT00237770",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1989",
"agreement_id": "2257",
"nct_id": "NCT00275561",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1990",
"agreement_id": "2307",
"nct_id": "NCT00297167",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Restrictions may vary in accordance with each agreement that is negotiated with individual investigators. Sponsor will allow publication after multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor\u2019s confidential information be removed from any publication and defer publication for period of time to allow Sponsor to obtain patent or other intellectual property right protection.'"
},
{
"ID": "1991",
"agreement_id": "2308",
"nct_id": "NCT00297232",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.'"
},
{
"ID": "1992",
"agreement_id": "2309",
"nct_id": "NCT00318292",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1993",
"agreement_id": "2310",
"nct_id": "NCT00318370",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "1994",
"agreement_id": "2311",
"nct_id": "NCT00318409",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1995",
"agreement_id": "2312",
"nct_id": "NCT00318461",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Novo Nordisk acknowledges the Investigator\u2019s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication\/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.'"
},
{
"ID": "1996",
"agreement_id": "2313",
"nct_id": "NCT00318474",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1997",
"agreement_id": "2314",
"nct_id": "NCT00283595",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1998",
"agreement_id": "2315",
"nct_id": "NCT00283686",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "1999",
"agreement_id": "2316",
"nct_id": "NCT00283712",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2000",
"agreement_id": "2574",
"nct_id": "NCT00352105",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2001",
"agreement_id": "2575",
"nct_id": "NCT00352118",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2002",
"agreement_id": "2576",
"nct_id": "NCT00352365",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2003",
"agreement_id": "2679",
"nct_id": "NCT00389974",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2004",
"agreement_id": "2680",
"nct_id": "NCT00390182",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2005",
"agreement_id": "2681",
"nct_id": "NCT00390234",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2006",
"agreement_id": "2682",
"nct_id": "NCT00390364",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2007",
"agreement_id": "2683",
"nct_id": "NCT00357994",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "AbbVie requests that any investigator or institution that plans on presenting\/publishing results disclosure, provide written notification of their request 60 days prior to their presentation\/publication. AbbVie requests that no presentation\/publication will be instituted until 12 months after a study is completed, or after the first presentation\/publication whichever occurs first. A delay may be proposed of a presentation\/publication if AbbVie needs to secure patent or proprietary protection.'"
},
{
"ID": "2008",
"agreement_id": "2684",
"nct_id": "NCT00358007",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2009",
"agreement_id": "2685",
"nct_id": "NCT00375999",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2010",
"agreement_id": "2686",
"nct_id": "NCT00376168",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2011",
"agreement_id": "2627",
"nct_id": "NCT00371176",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2012",
"agreement_id": "2628",
"nct_id": "NCT00371254",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2013",
"agreement_id": "2629",
"nct_id": "NCT00371267",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2014",
"agreement_id": "2630",
"nct_id": "NCT00371345",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2015",
"agreement_id": "2631",
"nct_id": "NCT00371397",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2016",
"agreement_id": "2632",
"nct_id": "NCT00371436",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2017",
"agreement_id": "2633",
"nct_id": "NCT00371449",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2018",
"agreement_id": "2634",
"nct_id": "NCT00371566",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": ": GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2019",
"agreement_id": "2740",
"nct_id": "NCT00377364",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2020",
"agreement_id": "2741",
"nct_id": "NCT00392925",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2021",
"agreement_id": "2742",
"nct_id": "NCT00393029",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2022",
"agreement_id": "1266",
"nct_id": "NCT00160693",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2023",
"agreement_id": "1267",
"nct_id": "NCT00160706",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2024",
"agreement_id": "1268",
"nct_id": "NCT00181623",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2025",
"agreement_id": "1269",
"nct_id": "NCT00181714",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2026",
"agreement_id": "1270",
"nct_id": "NCT00181766",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2027",
"agreement_id": "1271",
"nct_id": "NCT00181844",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2028",
"agreement_id": "1272",
"nct_id": "NCT00181883",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2029",
"agreement_id": "1273",
"nct_id": "NCT00182000",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2030",
"agreement_id": "1343",
"nct_id": "NCT00174915",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2031",
"agreement_id": "1344",
"nct_id": "NCT00174941",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2032",
"agreement_id": "1345",
"nct_id": "NCT00174954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2033",
"agreement_id": "2437",
"nct_id": "NCT00356863",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2034",
"agreement_id": "2438",
"nct_id": "NCT00356889",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2035",
"agreement_id": "2439",
"nct_id": "NCT00374335",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2036",
"agreement_id": "2440",
"nct_id": "NCT00374543",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2037",
"agreement_id": "2441",
"nct_id": "NCT00374803",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2038",
"agreement_id": "2442",
"nct_id": "NCT00374842",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2039",
"agreement_id": "2443",
"nct_id": "NCT00253981",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2040",
"agreement_id": "2444",
"nct_id": "NCT00254072",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2041",
"agreement_id": "2445",
"nct_id": "NCT00254293",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2042",
"agreement_id": "2446",
"nct_id": "NCT00254462",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2043",
"agreement_id": "2447",
"nct_id": "NCT00276016",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2044",
"agreement_id": "2687",
"nct_id": "NCT00376259",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "2045",
"agreement_id": "2688",
"nct_id": "NCT00376363",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2046",
"agreement_id": "2689",
"nct_id": "NCT00376506",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2047",
"agreement_id": "2690",
"nct_id": "NCT00376532",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2048",
"agreement_id": "2691",
"nct_id": "NCT00376675",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2049",
"agreement_id": "2812",
"nct_id": "NCT00321893",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2050",
"agreement_id": "2813",
"nct_id": "NCT00321906",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2051",
"agreement_id": "2814",
"nct_id": "NCT00321932",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2052",
"agreement_id": "2815",
"nct_id": "NCT00321984",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2053",
"agreement_id": "2816",
"nct_id": "NCT00322101",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2054",
"agreement_id": "2817",
"nct_id": "NCT00386243",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2055",
"agreement_id": "2818",
"nct_id": "NCT00386256",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2056",
"agreement_id": "2743",
"nct_id": "NCT00393068",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "2057",
"agreement_id": "2744",
"nct_id": "NCT00393094",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2058",
"agreement_id": "2745",
"nct_id": "NCT00393367",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2059",
"agreement_id": "2746",
"nct_id": "NCT00393380",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2060",
"agreement_id": "2747",
"nct_id": "NCT00393458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.'"
},
{
"ID": "2061",
"agreement_id": "2748",
"nct_id": "NCT00393484",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2062",
"agreement_id": "2749",
"nct_id": "NCT00393510",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2063",
"agreement_id": "2750",
"nct_id": "NCT00300755",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "2064",
"agreement_id": "2751",
"nct_id": "NCT00300885",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2065",
"agreement_id": "2897",
"nct_id": "NCT00358527",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI is not allowed to release any interim results of the Study without prior consent of the sponsor, and must provide 45 days written notice to the sponsor prior to public release to permit the sponsor's review. The PI can use the study results for his\/her own teaching, research, and publication purposes only, not for commercial purposes, except as authorized by the sponsor. No publication shall contain any trade secret or proprietary\/confidential information of the sponsor.'"
},
{
"ID": "2066",
"agreement_id": "1346",
"nct_id": "NCT00174967",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2067",
"agreement_id": "1347",
"nct_id": "NCT00175006",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2068",
"agreement_id": "1348",
"nct_id": "NCT00175019",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.'"
},
{
"ID": "2069",
"agreement_id": "1349",
"nct_id": "NCT00175877",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2070",
"agreement_id": "1350",
"nct_id": "NCT00176228",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2071",
"agreement_id": "1351",
"nct_id": "NCT00176254",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2072",
"agreement_id": "1352",
"nct_id": "NCT00176306",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2073",
"agreement_id": "1367",
"nct_id": "NCT00178178",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2074",
"agreement_id": "1368",
"nct_id": "NCT00178191",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2075",
"agreement_id": "1369",
"nct_id": "NCT00178256",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2076",
"agreement_id": "1370",
"nct_id": "NCT00178464",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2077",
"agreement_id": "2448",
"nct_id": "NCT00276094",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.'"
},
{
"ID": "2078",
"agreement_id": "2449",
"nct_id": "NCT00276159",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2079",
"agreement_id": "2450",
"nct_id": "NCT00276406",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2080",
"agreement_id": "2451",
"nct_id": "NCT00276419",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2081",
"agreement_id": "2452",
"nct_id": "NCT00276458",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2082",
"agreement_id": "2453",
"nct_id": "NCT00276484",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2083",
"agreement_id": "2454",
"nct_id": "NCT00276549",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2084",
"agreement_id": "2455",
"nct_id": "NCT00276614",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2085",
"agreement_id": "2456",
"nct_id": "NCT00276861",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2086",
"agreement_id": "2457",
"nct_id": "NCT00323037",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The publishing party will submit any proposed manuscript or publication to the sponsor for comment at least 60 days prior to its release. The publishing party will make every reasonable attempt to incorporate comments received from the sponsor, and will upon request remove any previously undisclosed confidential information, prior to publication or disclosure. There will be no publication or publicizing of individual site data or results prior to the multicenter publication.'"
},
{
"ID": "2087",
"agreement_id": "2458",
"nct_id": "NCT00323115",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2088",
"agreement_id": "2819",
"nct_id": "NCT00386308",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "'"
},
{
"ID": "2089",
"agreement_id": "2820",
"nct_id": "NCT00386334",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.'"
},
{
"ID": "2090",
"agreement_id": "2821",
"nct_id": "NCT00386360",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2091",
"agreement_id": "2822",
"nct_id": "NCT00386425",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2092",
"agreement_id": "2823",
"nct_id": "NCT00386477",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2093",
"agreement_id": "2824",
"nct_id": "NCT00386607",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.'"
},
{
"ID": "2094",
"agreement_id": "2577",
"nct_id": "NCT00352417",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 30 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable.'"
},
{
"ID": "2095",
"agreement_id": "2578",
"nct_id": "NCT00352612",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2096",
"agreement_id": "2579",
"nct_id": "NCT00352664",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2097",
"agreement_id": "2580",
"nct_id": "NCT00352690",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2098",
"agreement_id": "2581",
"nct_id": "NCT00352781",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2099",
"agreement_id": "2582",
"nct_id": "NCT00352846",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2100",
"agreement_id": "2898",
"nct_id": "NCT00358579",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2101",
"agreement_id": "2899",
"nct_id": "NCT00358644",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2102",
"agreement_id": "2900",
"nct_id": "NCT00358670",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.'"
},
{
"ID": "2103",
"agreement_id": "2901",
"nct_id": "NCT00358735",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2104",
"agreement_id": "2902",
"nct_id": "NCT00358826",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented as a joint, multi-center publication.'"
},
{
"ID": "2105",
"agreement_id": "2903",
"nct_id": "NCT00358917",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "This study has varying agreements that have been negotiated individually; however, it appears that the most restrictive of the agreements states that following the first publication\/presentation of the study by Abbott (or twelve [12] months after the completion of the study at all sites, whichever occurs first), the Principal Investigator (PI) shall, during a period of twelve (12) months, have the right to publish\/present the results of the site.'"
},
{
"ID": "2106",
"agreement_id": "2904",
"nct_id": "NCT00358956",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "2107",
"agreement_id": "2905",
"nct_id": "NCT00377403",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2108",
"agreement_id": "2906",
"nct_id": "NCT00377429",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The 1st publication of study results shall be a multicenter publication or disclosure coordinated by sponsor.'"
},
{
"ID": "2109",
"agreement_id": "Prior to submitting for publication, the Investigator shall allow sponsor at least 60 days to review the proposed Publication. Proposed Publications shall not include either Fresenius Biotech confidential information other than the study results or personal data on any patient. If parties disagree, parties will meet to discuss and resolve any disagreements.'",
"nct_id": "",
"pi_employee": "",
"restrictive_agreement": ""
},
{
"ID": "2110",
"agreement_id": "2907",
"nct_id": "NCT00377455",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2111",
"agreement_id": "2635",
"nct_id": "NCT00356915",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2112",
"agreement_id": "1371",
"nct_id": "NCT00178477",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2113",
"agreement_id": "1372",
"nct_id": "NCT00178503",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2114",
"agreement_id": "1373",
"nct_id": "NCT00178633",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2115",
"agreement_id": "1374",
"nct_id": "NCT00178685",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2116",
"agreement_id": "1375",
"nct_id": "NCT00178711",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2117",
"agreement_id": "1376",
"nct_id": "NCT00178919",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2118",
"agreement_id": "1377",
"nct_id": "NCT00179309",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2119",
"agreement_id": "1378",
"nct_id": "NCT00193479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "2120",
"agreement_id": "1379",
"nct_id": "NCT00193492",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the propsed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites'"
},
{
"ID": "2121",
"agreement_id": "1380",
"nct_id": "NCT00193596",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "2122",
"agreement_id": "2459",
"nct_id": "NCT00323193",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2123",
"agreement_id": "2460",
"nct_id": "NCT00323258",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2124",
"agreement_id": "2461",
"nct_id": "NCT00323271",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2125",
"agreement_id": "2462",
"nct_id": "NCT00323284",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2126",
"agreement_id": "2463",
"nct_id": "NCT00323297",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "2127",
"agreement_id": "2464",
"nct_id": "NCT00323310",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.'"
},
{
"ID": "2128",
"agreement_id": "2465",
"nct_id": "NCT00323362",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The CINJ PI, and all co-authors, prior to submission or use, must review any abstract or manuscript.'"
},
{
"ID": "2129",
"agreement_id": "2466",
"nct_id": "NCT00323427",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2130",
"agreement_id": "2467",
"nct_id": "NCT00323479",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2131",
"agreement_id": "2468",
"nct_id": "NCT00323492",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "After conclusion of the study and without prior written approval from Gilead Sciences, investigators in this study may communicate, orally present, or publish in scientific journals or other scholarly media only after the following conditions have been met: results of the study in their entirety have been publicly disclosed by or with the consent of Gilead Sciences in an abstract, manuscript, or presentation form; or study has been completed at all study sites for at least 2 years.'"
},
{
"ID": "2132",
"agreement_id": "2469",
"nct_id": "NCT00323557",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2133",
"agreement_id": "2583",
"nct_id": "NCT00352885",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2134",
"agreement_id": "2584",
"nct_id": "NCT00352911",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2135",
"agreement_id": "2585",
"nct_id": "NCT00353119",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2136",
"agreement_id": "2586",
"nct_id": "NCT00409786",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2137",
"agreement_id": "2587",
"nct_id": "NCT00409825",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2138",
"agreement_id": "2588",
"nct_id": "NCT00409838",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.'"
},
{
"ID": "2139",
"agreement_id": "2589",
"nct_id": "NCT00410046",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "2140",
"agreement_id": "2692",
"nct_id": "NCT00376688",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2141",
"agreement_id": "2693",
"nct_id": "NCT00376805",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2142",
"agreement_id": "2694",
"nct_id": "NCT00376935",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Restriction Description:In accordance with the Clinical Trial Agreement between NIAID (DAIDS)and company collaborators,NIAID provides companies with a copy of any abstract,press release,or manuscript prior to submission for publication with sufficient time for company review and comment.The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and 5 business days for abstracts,to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "2143",
"agreement_id": "2695",
"nct_id": "NCT00376948",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2144",
"agreement_id": "2636",
"nct_id": "NCT00357006",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2145",
"agreement_id": "2637",
"nct_id": "NCT00357032",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2146",
"agreement_id": "2638",
"nct_id": "NCT00357097",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.'"
},
{
"ID": "2147",
"agreement_id": "2639",
"nct_id": "NCT00357110",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI will provide ASTRAZENECA as soon as possible with preliminary data and drafts of proposed results communications and with the proposed final draft at least 14 days prior to submission of an abstract and 30 days prior to submission of a manuscript. ASTRAZENECA can, upon written request, embargo communications regarding trial results for no more than 45 days from the date of the written request. ASTRAZENECA cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2148",
"agreement_id": "2640",
"nct_id": "NCT00357162",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2149",
"agreement_id": "2641",
"nct_id": "NCT00357500",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2150",
"agreement_id": "2642",
"nct_id": "NCT00357552",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication\/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.'"
},
{
"ID": "2151",
"agreement_id": "2643",
"nct_id": "NCT00357903",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.'"
},
{
"ID": "2152",
"agreement_id": "2644",
"nct_id": "NCT00357955",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2153",
"agreement_id": "2645",
"nct_id": "NCT00357968",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2154",
"agreement_id": "1381",
"nct_id": "NCT00193609",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The sponsor can review\/embargo results communications prior to public release for a period that is >60 days but \u2264180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and\/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.'"
},
{
"ID": "2155",
"agreement_id": "1382",
"nct_id": "NCT00194012",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2156",
"agreement_id": "1383",
"nct_id": "NCT00194025",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2157",
"agreement_id": "1384",
"nct_id": "NCT00194077",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2158",
"agreement_id": "1385",
"nct_id": "NCT00194129",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2159",
"agreement_id": "1386",
"nct_id": "NCT00194532",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2160",
"agreement_id": "1387",
"nct_id": "NCT00194610",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2161",
"agreement_id": "1388",
"nct_id": "NCT00194675",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2162",
"agreement_id": "1389",
"nct_id": "NCT00194896",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2163",
"agreement_id": "1390",
"nct_id": "NCT00195260",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "2164",
"agreement_id": "1391",
"nct_id": "NCT00195273",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.'"
},
{
"ID": "2165",
"agreement_id": "1403",
"nct_id": "NCT00215150",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2166",
"agreement_id": "2470",
"nct_id": "NCT00388804",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2167",
"agreement_id": "2471",
"nct_id": "NCT00388947",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "AMS (sponsor) is the sole owner of the conglomerate data inputted into the POWER database and has the right to publish such data at its sole discretion. Registry Physician will provide AMS with a copy of any data, finding, result, article, abstract, manuscripts, presentation, or other information intended for publication, at least thirty (30) days prior to submission of same for publication.'"
},
{
"ID": "2168",
"agreement_id": "2472",
"nct_id": "NCT00388973",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI agrees to collaborate in good faith with AstraZeneca with regard to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca.'"
},
{
"ID": "2169",
"agreement_id": "2473",
"nct_id": "NCT00389064",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI agrees to collaborate in good faith with AstraZeneca with regards to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca'"
},
{
"ID": "2170",
"agreement_id": "2474",
"nct_id": "NCT00389168",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2171",
"agreement_id": "2475",
"nct_id": "NCT00389207",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.'"
},
{
"ID": "2172",
"agreement_id": "2476",
"nct_id": "NCT00389324",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Institution or Principal investigator (PI) furnishes Talecris a copy of any proposed publication (either in writing or oral) of results of the study performed under the protocol, at least 30 days before the date of submission for publication or presentation. Talecris can ask the Principal Investigator to remove Confidential Information before publication or Talecris shall have an additional time, not to exceed 60 days, to file a patent application for such Confidential Information.'"
},
{
"ID": "2173",
"agreement_id": "2477",
"nct_id": "NCT00389441",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.'"
},
{
"ID": "2174",
"agreement_id": "2478",
"nct_id": "NCT00389467",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2175",
"agreement_id": "2479",
"nct_id": "NCT00389493",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2176",
"agreement_id": "2480",
"nct_id": "NCT00403481",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If identified by Daiichi Sankyo Inc., any of DSI's confidential information, as defined to the author, shall be deleted. Nothing in our site agreement shall be taken as giving Daiichi Sankyo, Inc. any right of editorial control over any publication prepared by the study site.'"
},
{
"ID": "2177",
"agreement_id": "2696",
"nct_id": "NCT00376961",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2178",
"agreement_id": "2697",
"nct_id": "NCT00278863",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2179",
"agreement_id": "2698",
"nct_id": "NCT00278876",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2180",
"agreement_id": "2699",
"nct_id": "NCT00278889",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.'"
},
{
"ID": "2181",
"agreement_id": "2700",
"nct_id": "NCT00278915",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The PI cannot disclose or publish any Confidential Information to do with the trial without consent from AstraZeneca, and, for other information, the PI must withhold from publishing or presenting for 90 days if requested to do so by AstraZeneca.'"
},
{
"ID": "2182",
"agreement_id": "2701",
"nct_id": "NCT00278954",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Publication of the Study results will be allowed only with prior written approval from Sponsor, said consent not to be unreasonably withheld. At the request of Sponsor, the Institution and\/or Investigator shall delete any Confidential Information pertaining to Sponsor's Inventions from any proposed publications prior to submitting or presenting the materials. Any and all publications will give appropriate recognition of any support received from Sponsor.'"
},
{
"ID": "2183",
"agreement_id": "2702",
"nct_id": "NCT00278993",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2184",
"agreement_id": "2703",
"nct_id": "NCT00279201",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.'"
},
{
"ID": "2185",
"agreement_id": "2825",
"nct_id": "NCT00386776",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2186",
"agreement_id": "2826",
"nct_id": "NCT00386880",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2187",
"agreement_id": "2827",
"nct_id": "NCT00387010",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Sponsor has the right 60 days before submission for publication to review\/provide comments. If the Sponsor\u2019s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor\u2019s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.'"
},
{
"ID": "2188",
"agreement_id": "2915",
"nct_id": "NCT00280566",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion\/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.'"
},
{
"ID": "2189",
"agreement_id": "2916",
"nct_id": "NCT00280683",
"pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID": "2190",
"agreement_id": "2917",
"nct_id": "NCT00280826",
"pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.",
"restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.'"
},
{
"ID"